rhijn b and not rhijn bd - Search Results

Year	Number of Results
2000	2
2001	3
2002	4
2003	3
2004	2
2005	3
2008	2
2009	4
2010	11
2011	11
2012	18
2013	14
2014	20
2015	19
2016	28
2017	22
2018	31
2019	22
2020	33
2021	27
2022	27
2023	40
2024	22
2025	30
2026	15

1

Individual Patient Data Validation of the EAU Definitions of BCG Failure in Patients with Non-muscle-invasive Urothelial Carcinoma of the Bladder: An International Multicenter Retrospective Study.

Gontero P, Soria F, Babjuk M, Burger M, Palou Redorta J, D'Andrea D, Pradere B, Moschini M, Birtle A, Compérat EM, Dominguez-Escrig JL, Liedberg F, Mariappan P, van Rhijn BWG, Seisen T, Shariat SF, Teoh J, Xylinas E, Capoun O, Rai BP, Soukup V, Faba OR, Cohen D, Foster L, Beaud N, Girtner F, Breyer J, Hornak J, Einerhand SMH, Anract J, Bobjer J, Linares E, Rodriguez-Serranos A, Cathomas R, Saba K, Hernandez V, Lorente C, Rouanne M, Lebret T, Masson-Lecomte A, Rouprêt M, Sylvester RJ. Gontero P, et al. Among authors: van rhijn bwg. Eur Urol Oncol. 2026 May 20:S2588-9311(26)00132-X. doi: 10.1016/j.euo.2026.05.005. Online ahead of print. Eur Urol Oncol. 2026. PMID: 42161743

2

Diagnostic Accuracy of Liquid-Based Biomarkers for Detecting and Risk Stratifying Upper Tract Urothelial Cancers: A Diagnostic Test Systematic Review by the EAU Guidelines UTUC Panel.

Rai BP, Rajan K, Rajan P, Pradere B, Capoun O, Soukup V, Gontero P, Soria F, Birtle A, Compérat EM, Dominguez-Escrig JL, Yuan Y, Liedberg F, Rouprêt M, Seisen T, Teoh JY, Moschini M, Mariappan P, Shariat SF, Xylinas E, Baard J, D'Andrea D, van Rhijn BWG, Masson-Lecomte A. Rai BP, et al. Among authors: van rhijn bwg. Eur Urol Oncol. 2026 May 14:S2588-9311(26)00120-3. doi: 10.1016/j.euo.2026.04.011. Online ahead of print. Eur Urol Oncol. 2026. PMID: 42135124 Free article. Review.

3

Neoadjuvant Intravesical Therapy for Patients with Non-muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis.

Zaurito P, Scilipoti P, Santangelo A, Birtle A, Makaroff L, Compérat E, Dominguez-Escrig JL, Liedberg F, Mariappan P, Masson-Leconmte A, Teoh JY, Pradere B, Rai BP, van Rhijn BWG, Seisen T, Shariat SF, D'Andrea D, Soria F, Wood R, Xylinas E, Montorsi F, Briganti A, Gontero P, Moschini M; European Association of Urology (EAU) Guidelines Panel on Non-muscle-invasive Bladder Cancer. Zaurito P, et al. Among authors: van rhijn bwg. Eur Urol Oncol. 2026 May 12:S2588-9311(26)00119-7. doi: 10.1016/j.euo.2026.04.010. Online ahead of print. Eur Urol Oncol. 2026. PMID: 42120270 Review.

4

Genetic characteristics and targeted treatments of primary bladder and urachal adenocarcinomas: a systematic review with pooled descriptive genomic analyses.

Dér B, Váradi M, Nagy N, Kubik A, Paner GP, Iyer G, Gaisa NT, Wobker SE, Bambury R, van Rhijn BWG, Al-Ahmadie H, Nyirády P, Reis H, Szarvas T. Dér B, et al. Among authors: van rhijn bwg. Cancer Metastasis Rev. 2026 May 1;45(2):26. doi: 10.1007/s10555-026-10332-3. Cancer Metastasis Rev. 2026. PMID: 42062619 Free PMC article. Review.

5

International Society of Urological Pathology Consensus on Cancer Precursor Lesions: Working Group 3 Preneoplastic and Precursor Lesions of the Kidney.

Williamson SR, Wobker SE, Mehra R, Al-Obaidy KI, Martignoni G, Mohanty S, Smith SC, Tan PH, Tretiakova M, Kapur P, Wu CL, Akgul M, Sangoi AR, Hakimi AA, Shuch B, Brugarolas J, Kristiansen G, Cheng L, Moch H; And the Members of the ISUP GU Cancer Precursor Consensus Panel. Williamson SR, et al. Am J Surg Pathol. 2026 Jun 1;50(6):e32-e47. doi: 10.1097/PAS.0000000000002550. Epub 2026 Apr 29. Am J Surg Pathol. 2026. PMID: 42054499 Review.

6

Redefining the Landscape of Genitourinary Cancer Precursors: The International Society of Urological Pathology Consensus Recommendations.

Cheng L, Iczkowski KA, van Leenders GJLH, Downes MR, Raspollini MR, Williamson SR, Moch H, Bremmer F, Tickoo SK, Menon S, Cubilla AL, Kristiansen G; Members of ISUP GU Cancer Precursor Consensus Panel. Cheng L, et al. Eur Urol. 2026 Jun;89(6):483-486. doi: 10.1016/j.eururo.2026.03.006. Epub 2026 Apr 3. Eur Urol. 2026. PMID: 41934039

7

Active surveillance in low-grade NMIBC - results of an international two-round modified Delphi consensus.

Contieri R, Gontero P, Hurle R, Afferi L, Albisinni S, Babjuk M, Birtle A, Black P, Brausi M, Bruins M, Čapoun O, Carrion A, Catto J, Choudhury A, Cimadamore A, Comperat E, Daneshmand S, D'andrea D, Del Giudice F, Escrig JLD, Hensley P, Krajewski W, Laukhtina E, Li R, Liedberg F, Lotan Y, Marcq G, Mariappan P, Mari A, Martini A, Lecomte AM, Meijer R, Mir MC, Mori K, Moschini M, Mostafid H, O'Donnell M, Palou J, Panebianco V, Perdonà S, Porten S, Psutka S, Rink M, Roupret M, Seisen T, Soloway M, Soukup V, Steinberg G, Stenzl A, Teoh JY, Tully K, van der Heijden T, van Rhijn BWG, Witjes A, Xylinas E, Kamat AM, Pradere B, Mertens LS. Contieri R, et al. Among authors: van rhijn bwg. Nat Rev Urol. 2026 Apr 1. doi: 10.1038/s41585-026-01137-8. Online ahead of print. Nat Rev Urol. 2026. PMID: 41922791 Review.

8

Risk stratification and conditional recurrence after radical cystectomy: toward adaptive follow-up.

Contieri R, Martini A, Furrer M, D'Andrea D, Claps F, von Deimling M, Soria F, Mari A, Bianchi L, Tonin E, Flippot R, Teoh JYC, Marcq G, Desprez PE, Pichler R, Ślusarczyk A, Subiela JD, Del Giudice F, Santarelli V, Porreca A, Amodeo A, Pavan N, Simonato A, Scilipoti P, Perdonà S, Gontero P, van Rhijn BW, Hurle R, Moschini M, Pradere B, Mertens LS; European Association of Urology‐Young Academic Urologists (EAU‐YAU), Urothelial Carcinoma Working Group. Contieri R, et al. Among authors: van rhijn bw. BJU Int. 2026 Jun;137(6):1058-1066. doi: 10.1111/bju.70232. Epub 2026 Mar 12. BJU Int. 2026. PMID: 41821206

9

Diagnostic Value of Fluorine-18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Staging Histological Subtypes of Invasive Bladder Cancer.

Lijnen RAG, Ringia JB, Claps F, Vogel WV, Boellaard TN, van Rhijn BWG, Braat AJAT, Mertens LS. Lijnen RAG, et al. Among authors: van rhijn bwg. Eur Urol Oncol. 2026 Mar 6:S2588-9311(26)00046-5. doi: 10.1016/j.euo.2026.02.009. Online ahead of print. Eur Urol Oncol. 2026. PMID: 41794597

10

Ipilimumab and nivolumab followed by chemoradiotherapy as bladder-sparing treatment in muscle-invasive bladder cancer: a phase 2 trial.

Mellema JJ, Stockem CF, Herberts C, Cheung SK, Vis DJ, van Rhijn BWG, Mertens LS, Boellaard TN, van Montfoort ML, Balduzzi S, de Feijter JM, van der Mijn JCK, Sharma S, El Naggar AC, Boormans JL, Franckena M, Meijer RP, Noteboom JL, Schaake EE, Robbrecht DGJ, Suelmann BBM, van der Heijden MS. Mellema JJ, et al. Among authors: van rhijn bwg. Nat Med. 2026 Apr;32(4):1241-1248. doi: 10.1038/s41591-026-04271-3. Epub 2026 Feb 27. Nat Med. 2026. PMID: 41760951 Clinical Trial.

11

International Society of Urological Pathology (ISUP) Consensus Conference on Precursor Lesions: Working Group 4 Precursor Lesions of Testis Results of a Premeeting Survey.

Bremmer F, Colecchia M, Collins K, Acosta AM, Gupta S, Gordetsky JB, Maclean F, Meyts ER, Dieckmann KP, Kaushal S, Srigley JR, Adra N, Gilligan T, Daugaard G, Looijenga LHJ, Kristiansen G, Cheng L, Tickoo SK; Members of the ISUP GU Cancer Precursor Consensus Panel. Bremmer F, et al. Am J Surg Pathol. 2026 Jun 1;50(6):e21-e31. doi: 10.1097/PAS.0000000000002523. Epub 2026 Feb 23. Am J Surg Pathol. 2026. PMID: 41724745

12

Efficacy and safety of active surveillance and chemoablation in the management of non-muscle invasive bladder cancer (NMIBC): Systematic review and pooled analysis by the European Association of Urology-Young Academic Urologists: Urothelial Carcinoma Working Group.

Saouli A, Contieri R, Quhal F, Hurle R, Guenouni M, Ploussard G, Mori K, Yanagisawa T, Pradere B, Laukhtina E, Rajwa P, Albisinni S, Krajewski W, Cimadamore A, Del Giudice F, Gómez Rivas J, Soria F, Shariat SF, Gontero P, Mertens LS, van Rhijn BWG, AlShammari M, Gallioli A, Moschini M. Saouli A, et al. Among authors: van rhijn bwg. Actas Urol Esp (Engl Ed). 2026 Mar;50(2):501917. doi: 10.1016/j.acuroe.2026.501917. Epub 2026 Jan 5. Actas Urol Esp (Engl Ed). 2026. PMID: 41500450 Review. English, Spanish.

13

Perioperative and Oncological Outcomes of Distal Ureterectomy for Upper Tract Urothelial Carcinoma (UTUC): A Multicentre Study from the European Association of Urology Non-muscle-invasive Bladder Cancer/UTUC Guidelines Panels with a Focus on Survival Free from Ipsilateral UTUC Recurrence.

Soria F, Liedberg F, Stahl E, Dominguez-Escrig JL, Moschini M, Pradere B, D'Andrea D, Teoh JY, Capoun O, Soukup V, Rai BP, Birtle A, Compérat EM, Mariappan P, van Rhijn BWG, Baard J, Seisen T, Xylinas EN, Shariat SF, Gontero P, Masson-Lecomte A. Soria F, et al. Among authors: van rhijn bwg. Eur Urol Oncol. 2025 Dec 31:S2588-9311(25)00328-1. doi: 10.1016/j.euo.2025.12.002. Online ahead of print. Eur Urol Oncol. 2025. PMID: 41478781

14

Is histological grade a useful parameter in muscle-invasive urothelial bladder cancer? Results from a multicenter study on the impact of different grading systems on disease-free survival after upfront radical cystectomy.

Rinderknecht E, Claps F, Bostrom PJ, Shariat SF, Neuzillet Y, Zlotta AR, Trombetta C, Eckstein M, Lijnen RAG, Mertens LS, Bussani R, Burger M, van Leenders GJLH, Boormans JL, Wullich B, Hartmann A, Pavan N, Pouessel D, van der Kwast TH, Allory Y, Zuiverloon TCM, Lotan Y, van Rhijn BWG, Mayr R. Rinderknecht E, et al. Among authors: van rhijn bwg. World J Urol. 2025 Nov 20;43(1):705. doi: 10.1007/s00345-025-06089-z. World J Urol. 2025. PMID: 41264026 Free PMC article.

15

Current surveillance in the Netherlands for urothelial carcinoma in lynch syndrome.

Doornweerd BHJ, Kikkert RR, Koornstra JJ, van Rhijn BWG, van Gennep EJ, Langers AMJ, de Jong IJ, van Leerdam ME. Doornweerd BHJ, et al. Among authors: van rhijn bwg. Fam Cancer. 2025 Oct 18;24(4):77. doi: 10.1007/s10689-025-00503-6. Fam Cancer. 2025. PMID: 41108504 Free PMC article.

16

Development and International Evaluation of an Artificial Intelligence-based Model (PROGRxN-BCa) Using the World Health Organization 2004/2022 Grading System to Predict Progression Risk and Improve Substratification for Non-muscle-invasive Bladder Cancer.

Kwong JCC, Al-Daqqaq Z, Chelliahpillai Y, Lee S, Kim K, Ringa M, Feifer A, Lajkosz K, Wettstein MS, Chan A, Lee T, Nguyen M, Kassouf W, Black PC, Breau RH, Lodde M, Fairey A, Lattouf JB, Jeldres C, Rendon R, Alimohamed N, Fleshner NE, Diamand R, Gontero P, Sylvester RJ, van Rhijn BWG, Kamat AM, Johnson AEW, Zlotta AR, Kulkarni GS; PROGRxN-BCa Consortium. Kwong JCC, et al. Among authors: van rhijn bwg. Eur Urol. 2026 May;89(5):404-413. doi: 10.1016/j.eururo.2025.09.4145. Epub 2025 Oct 7. Eur Urol. 2026. PMID: 41062388

17

Applicability of the European Association of Urology 2021 Prognostic Model for Non-muscle-invasive Bladder Cancer in a Swedish Population-based Cohort.

Liedberg F, Hagberg O, Beijert IJ, Aljabery F, Gårdmark T, Hosseini A, Jahnson S, Jerlström T, Kjölhede H, Malmström PU, Ströck V, Söderkvist K, Ullén A, van Rhijn BWG, Holmberg L, Häggström C. Liedberg F, et al. Among authors: van rhijn bwg. Eur Urol Open Sci. 2025 Sep 4;80:33-37. doi: 10.1016/j.euros.2025.08.003. eCollection 2025 Oct. Eur Urol Open Sci. 2025. PMID: 40979267 Free PMC article.

18

Final clinical analysis of pre-operative ipilimumab and nivolumab in locally advanced urothelial cancer and exploration of tumor-draining lymph node composition: The NABUCCO trial.

Stockem CF, van Dorp J, van Dijk N, Vis DJ, Harkes R, van den Broek B, Alkemade M, Broeks A, Hendricksen K, Boellaard TN, de Feijter JM, van Montfoort ML, Daletzakis A, van der Heijden AG, Meijer RP, Mehra N, Wessels LFA, van Rhijn BWG, Suelmann BBM, van der Heijden MS. Stockem CF, et al. Among authors: van rhijn bwg. Eur J Cancer. 2025 Oct 16;229:115731. doi: 10.1016/j.ejca.2025.115731. Epub 2025 Aug 21. Eur J Cancer. 2025. PMID: 40934711 Clinical Trial.

19

Routine annual imaging does not aid in diagnosing new functional complications more than five years after RC with ileal conduit.

Ringia JB, Scholte FEF, Lijnen RAG, Algie E, Einerhand SMH, Wit EMK, van de Kamp MW, Boellaard TN, van der Poel HG, van Rhijn BWG, Mertens LS, Hendricksen K. Ringia JB, et al. Among authors: van rhijn bwg. World J Urol. 2025 Sep 3;43(1):539. doi: 10.1007/s00345-025-05903-y. World J Urol. 2025. PMID: 40900177

20

Letter: Updates to Microhematuria: AUA/SUFU Guideline (2025).

Shariat SF, van Rhijn BWG, Bolenz C, Witjes JA, Burger M, Schmitz-Dräger BJ. Shariat SF, et al. Among authors: van rhijn bwg. J Urol. 2025 Dec;214(6):657-658. doi: 10.1097/JU.0000000000004714. Epub 2025 Aug 22. J Urol. 2025. PMID: 40843936 No abstract available.

21

International Society of Urological Pathology (ISUP) Multidisciplinary Consensus on Premalignant and Putative Precursor Lesions of Penile Cancer: Working Group 5 report on Terminology, Grading, and Molecular Testing Practices.

Menon S, Sanchez DF, Chaux A, Giannico GA, Oliveira P, Necchi A, Regauer S, Speiss PE, Tamboli P, Tsuzuki T, Elsa F V, Kristiansen G, Cheng L, Cubilla A; Members of the ISUP GU Cancer Precursor Panel. Menon S, et al. Am J Surg Pathol. 2026 Jun 1;50(6):e6-e20. doi: 10.1097/PAS.0000000000002453. Epub 2025 Aug 20. Am J Surg Pathol. 2026. PMID: 40826809

22

The Dublin International Society of Urological Pathology (ISUP) Consensus Conference on Best Practice Recommendations on the Pathology of Glandular Lesions of the Urinary Bladder.

Paner GP, Al-Ahmadie H, Gaisa NT, Lopez-Beltran A, Maclean F, Tsuzuki T, Werneck da Cunha I, Amin MB, Aning J, Aron M, Athanazio D, Bambury RM, Cheng L, Gopalan A, Gulmann C, Guo CC, Harris C, Iyer G, Jimenez RE, Jinzaki M, Kikuchi E, Lal P, Miyai K, Netto GJ, Pan CC, Panebianco V, van Rhijn BW, Siefker-Radtke A, Smith SC, Szarvas T, Wobker SE, Kristiansen G, Reis H; ISUP Expert Panel On Urachal Neoplasms and Urinary Bladder Glandular Lesions. Paner GP, et al. Among authors: van rhijn bw. Adv Anat Pathol. 2026 Jan 1;33(1):1-16. doi: 10.1097/PAP.0000000000000510. Epub 2025 Aug 4. Adv Anat Pathol. 2026. PMID: 40757456

23

Sentinel lymph node staging in urological cancer surgery: advances in imaging, intra-operative detection and translational research.

van Gennep EJ, KleinJan GH, Kuusk T, Verdijk RWA, Wit EMK, van Rhijn BWG, Bex A, Mertens LS. van Gennep EJ, et al. Among authors: van rhijn bwg. BJU Int. 2025 Dec;136(6):979-989. doi: 10.1111/bju.16848. Epub 2025 Jul 12. BJU Int. 2025. PMID: 40650565 Free PMC article. Review.

24

Brück K, Atema V, Leliveld AM, Franckena M, Meijer RP, van der Heijden MS, Donders AR, Witjes JA, Uyl-de Groot CA, van Hoogstraten LMC, Kiemeney LA, Boormans JL, Aben KKH, Hulshof MCCM; CRAC study group and the BlaZIB study group. Brück K, et al. Int J Radiat Oncol Biol Phys. 2025 Nov 15;123(4):1004-1017. doi: 10.1016/j.ijrobp.2025.06.3866. Epub 2025 Jul 3. Int J Radiat Oncol Biol Phys. 2025. PMID: 40614785 Free article.

25

The role of primary tumour site surgery in metastatic UTUC: a systematic review and meta-analysis.

Cella L, Moretto S, Contieri R, Uleri A, Avolio PP, Piccolini A, Calabrese B, Fasulo V, Hurle R, Lazzeri M, Saita A, Mertens LS, van Rhijn BWG, Pradere B, Cole AP, Seisen T, Casale P, Lughezzani G, Buffi NM, Paciotti M. Cella L, et al. Among authors: van rhijn bwg. BJU Int. 2025 Oct;136(4):602-611. doi: 10.1111/bju.16836. Epub 2025 Jul 3. BJU Int. 2025. PMID: 40607943

26

International Society of Urological Pathology Consensus Meeting 2024: Working Group 2 Preneoplastic and Precursor Lesions of the Urinary Bladder.

Downes MR, Lopez-Beltran A, Contieri R, Hansel DE, Paner GP, Shen S, van Rhijn BWG, Al-Ahmadie H, Amin MB, Brunelli M, Comperat E, Cookson MS, Faltas BM, Guo CC, Hartmann A, Kamat AM, Mertens LS, Ross JS, van der Kwast TH, Warrick J, Kristiansen G, Cheng L, Raspollini MR; Members of ISUP GU Cancer Precursor Consensus Panel. Downes MR, et al. Among authors: van rhijn bwg. Am J Surg Pathol. 2025 Dec 1;49(12):e46-e57. doi: 10.1097/PAS.0000000000002440. Epub 2025 Jul 1. Am J Surg Pathol. 2025. PMID: 40590266 Free article.

27

Evaluating follow-up in patients with lymph node-negative penile cancer at a high-volume centre.

Vreeburg MTA, Vaessen GM, de Vries HM, Heeres BC, van Dijk-de Haan MC, van der Noort V, van Muilekom EH, van Kesteren J, Graafland NM, Hendricksen K, van Rhijn BWG, van der Poel HG, Brouwer OR. Vreeburg MTA, et al. Among authors: van rhijn bwg. BJU Int. 2025 Oct;136(4):675-681. doi: 10.1111/bju.16838. Epub 2025 Jun 23. BJU Int. 2025. PMID: 40551380

28

International Society of Urological Pathology Consensus on Cancer Precursor Lesions. Working Group 1: The Prostate.

Iczkowski KA, De Marzo AM, Agarwal N, Berman DM, Cimadamore A, Fine SW, Greenland N, Khani F, Loda M, Lotan TL, Varma M, Chinnaiyan A, Giannarini G, Huang J, Montironi R, Netto GJ, Osunkoya AO, Ratliff T, Kristiansen G, Cheng L, van Leenders GJLH; Members of the ISUP GU Cancer Precursor Consensus Panel. Iczkowski KA, et al. Am J Surg Pathol. 2025 Dec 1;49(12):e33-e45. doi: 10.1097/PAS.0000000000002430. Epub 2025 Jun 23. Am J Surg Pathol. 2025. PMID: 40545966 Free PMC article.

29

Prognostic Role of Serum IL-6 Levels in Bladder Cancer Patients and Hints of its Origin.

Engelmann SU, Pickl C, Haas M, Kasparbauer F, Rinderknecht E, Kälble S, van Rhijn BWG, Siska PJ, Decking SM, Renner K, Pichler R, Burger M, Gužvić M, Mayr R. Engelmann SU, et al. Among authors: van rhijn bwg. Clin Genitourin Cancer. 2025 Aug;23(4):102378. doi: 10.1016/j.clgc.2025.102378. Epub 2025 May 20. Clin Genitourin Cancer. 2025. PMID: 40514270 Free article.

30

Biomarker Analysis and Treatment Dynamics Following Preoperative Ipilimumab plus Nivolumab in Locally Advanced Urothelial Cancer from the Phase IB NABUCCO Study.

Stockem CF, Gil-Jimenez A, Ali H, van Dorp J, van Dijk N, van Montfoort ML, Alkemade M, Broeks A, Seignette IM, Hooijberg E, Brugman W, Voogd R, van Rhijn BWG, Mertens LS, de Feijter JM, Mehra N, van der Heijden AG, Meijer RP, Suelmann BBM, Scheper W, Wessels LFA, Vis DJ, van der Heijden MS. Stockem CF, et al. Among authors: van rhijn bwg. Clin Cancer Res. 2025 Sep 15;31(18):3897-3906. doi: 10.1158/1078-0432.CCR-25-0419. Clin Cancer Res. 2025. PMID: 40489082 Clinical Trial.

31

The Dublin International Society of Urological Pathology (ISUP) Consensus Conference on Best Practice Recommendations on the Pathology of Urachal Neoplasms.

Reis H, Al-Ahmadie H, Gaisa NT, Lopez-Beltran A, Maclean F, Tsuzuki T, Werneck da Cunha I, Amin MB, Aning J, Aron M, Athanazio D, Bambury RM, Cheng L, Gopalan A, Gulmann C, Guo CC, Harris C, Iyer G, Jimenez RE, Jinzaki M, Kikuchi E, Lal P, Miyai K, Netto GJ, Pan CC, Panebianco V, van Rhijn BW, Siefker-Radtke A, Smith SC, Szarvas T, Wobker SE, Kristiansen G, Paner GP; ISUP Expert Panel on Urachal Neoplasms and Urinary Bladder Glandular Lesions. Reis H, et al. Among authors: van rhijn bw. Am J Surg Pathol. 2025 Nov 1;49(11):e18-e26. doi: 10.1097/PAS.0000000000002416. Epub 2025 Jun 5. Am J Surg Pathol. 2025. PMID: 40471793 Free PMC article.

32

Towards Defining Follow-up Strategies for Patients with Primary Intermediate-risk Non-muscle-invasive Bladder Cancer.

Contieri R, Martini A, Beijert IJ, Mertens LS, Hentschel AE, Bründl J, Compérat EM, Plass K, Rodríguez O, Subiela Henríquez JD, Hernández V, de la Peña E, Alemany I, Turturica D, Pisano F, Soria F, Čapoun O, Bauerová L, Pešl M, Maxim Bruins H, Runneboom W, Herdegen S, Breyer J, Brisuda A, Calatrava A, Rubio-Briones J, Seles M, Mannweiler S, Bosschieter J, Kusuma VRM, Ashabere D, Huebner N, Seisen T, Claps F, Masson-Lecomte A, Liedberg F, Cohen D, Lunelli L, Cussenot O, Sheikh SE, Volanis D, Côté JF, Rouprêt M, Haitel A, Shariat SF, Mostafid AH, Nieuwenhuijzen JA, Zigeuner R, Dominguez-Escrig JL, Hacek J, Zlotta AR, Burger M, Evert M, de Kaa CAH, van der Heijden AG, Kiemeney LALM, Soukup V, Molinaro L, Hurle R, Paciotti M, Moschini M, Pradere B, Perdonà S, Gontero P, Llorente C, Algaba F, Palou J, N'Dow J, Ribal MJ, van der Kwast TH, Babjuk M, Sylvester RJ, van Rhijn BWG. Contieri R, et al. Among authors: van rhijn bwg. Eur Urol Oncol. 2025 Aug;8(4):977-985. doi: 10.1016/j.euo.2025.04.010. Epub 2025 May 21. Eur Urol Oncol. 2025. PMID: 40399193

33

Prospective clinical study of sentinel node detection in bladder cancer using a hybrid tracer - Towards replacement of pelvic lymph node dissection in cases with sentinel node visualization on SPECT/CT?

van Gennep EJ, Pisano G, KleinJan GH, Rietbergen DDD, Hendricksen K, Mertens LS, Vd Kamp MW, Wit EMK, van Montfoort ML, Donswijk M, van Rhijn BWG, van Leeuwen FWB, van der Poel HG. van Gennep EJ, et al. Among authors: van rhijn bwg. Eur J Nucl Med Mol Imaging. 2025 Aug;52(10):3653-3661. doi: 10.1007/s00259-025-07240-z. Epub 2025 Apr 4. Eur J Nucl Med Mol Imaging. 2025. PMID: 40183956 Free PMC article. Clinical Trial.

34

Hybrid 3-Tier Bladder Cancer Grade: The Mutually Beneficial Marriage of 2 Grading Systems.

Kamat AM, van Rhijn BWG, Van der Kwast T. Kamat AM, et al. Among authors: van rhijn bwg. J Urol. 2025 Jul;214(1):92-93. doi: 10.1097/JU.0000000000004542. Epub 2025 Mar 25. J Urol. 2025. PMID: 40132216 No abstract available.

35

European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: Summary of the 2025 Update.

Masson-Lecomte A, Birtle A, Pradere B, Capoun O, Compérat E, Domínguez-Escrig JL, Liedberg F, Makaroff L, Mariappan P, Moschini M, Rai BP, van Rhijn BWG, Shariat SF, Smith EJ, Teoh JYC, Soukup V, Wood R, Xylinas EN, Soria F, Seisen T, Gontero P. Masson-Lecomte A, et al. Among authors: van rhijn bwg. Eur Urol. 2025 Jun;87(6):697-716. doi: 10.1016/j.eururo.2025.02.023. Epub 2025 Mar 20. Eur Urol. 2025. PMID: 40118741

36

Survival in Responders and Nonresponders of Neoadjuvant and Induction Chemotherapy in Invasive Urothelial Carcinoma of the Urinary Bladder: A Clinical and Pathological Stage-Matched Analysis.

Reesink DJ, Voskuilen CS, van de Garde EMW, Hendricksen K, Horenblas S, van Melick HHE, van Rhijn BWG. Reesink DJ, et al. Among authors: van rhijn bwg. Clin Genitourin Cancer. 2025 Jun;23(3):102319. doi: 10.1016/j.clgc.2025.102319. Epub 2025 Feb 21. Clin Genitourin Cancer. 2025. PMID: 40113474

37

A Systematic Review and Meta-analysis of the Clinical Impact of Prophylactic Quinolones with Adjuvant Bacillus Calmette-Guérin Instillation for Non-muscle-invasive Bladder Cancer.

Wong CH, Ko IC, Leung DK, Yuen SK, Siu B, Yuan Y, Birtle A, Capoun O, Compérat E, Domínguez-Escrig JL, Liedberg F, Mariappan P, Moschini M, Pradere B, Rai BP, van Rhijn BWG, Seisen T, Shariat SF, Soria F, Soukup V, Xylinas EN, Masson-Lecomte A, Gontero P, Leung S, Teoh JY. Wong CH, et al. Among authors: van rhijn bwg. Eur Urol Oncol. 2025 Apr;8(2):571-580. doi: 10.1016/j.euo.2024.12.013. Epub 2025 Jan 28. Eur Urol Oncol. 2025. PMID: 39880747

38

Benefit and Harms of Radical Nephroureterectomy as Part of a Multimodal Treatment Strategy for Upper Tract Urothelial Carcinoma Patients Presenting with Clinical Evidence of Regional Lymph Node Metastasis: A Systematic Review and Meta-analysis by the European Association of Urology Guidelines.

Rai BP, Parmar K, Pradere B, Capoun O, Soukup V, Gontero P, Soria F, Birtle A, Compérat EM, Dominguez-Escrig JL, Yuan Y, Liedberg F, Mostafid H, Rouprêt M, Teoh JY, Moschini M, Mariappan P, van Rhijn BWG, Shariat SF, Xylinas E, Masson-Lecomte A, Seisen T. Rai BP, et al. Among authors: van rhijn bwg. Eur Urol Oncol. 2025 Jun;8(3):841-852. doi: 10.1016/j.euo.2024.12.009. Epub 2025 Jan 7. Eur Urol Oncol. 2025. PMID: 39779382

39

Multicenter Evaluation of Morbidity and Predictors of Response to Imiquimod Treatment for Penile Intraepithelial Neoplasia.

Avitan O, Elst L, Vreeburg M, Rafael T, Jordanova K, Graafland N, Hendricksen K, van Rhijn BWG, van der Poel HG, Albersen M, Brouwer O. Avitan O, et al. Among authors: van rhijn bwg. Eur Urol Open Sci. 2024 Dec 5;71:63-68. doi: 10.1016/j.euros.2024.08.020. eCollection 2025 Jan. Eur Urol Open Sci. 2024. PMID: 39703740 Free PMC article.

40

The role of intravesical chemotherapy following nephroureterectomy in upper tract urothelial carcinoma: A systematic review and meta-analysis.

Moretto S, Piccolini A, Gallioli A, Contieri R, Buffi N, Lughezzani G, Breda A, Baboudjian M, van Rhijn BW, Roupret M, Uleri A, Pradere B. Moretto S, et al. Among authors: van rhijn bw. Urol Oncol. 2025 Mar;43(3):191.e1-191.e12. doi: 10.1016/j.urolonc.2024.10.035. Epub 2024 Nov 25. Urol Oncol. 2025. PMID: 39592361

41

FGFR Inhibition in Urothelial Carcinoma.

Li R, Linscott J, Catto JWF, Daneshmand S, Faltas BM, Kamat AM, Meeks JJ, Necchi A, Pradere B, Ross JS, van der Heijden MS, van Rhijn BWG, Loriot Y. Li R, et al. Among authors: van rhijn bwg. Eur Urol. 2025 Feb;87(2):110-122. doi: 10.1016/j.eururo.2024.09.012. Epub 2024 Sep 30. Eur Urol. 2025. PMID: 39353825 Review.

42

The Importance of Being Grade 3: A Plea for a Three-tier Hybrid Classification System for Grade in Primary Non-muscle-invasive Bladder Cancer.

Beijert IJ, Hagberg O, Gårdmark T, Holmberg L, Häggström C, Johnston A, Trail M, Hamid S, Dreyer BA, Padovani L, Garau R, Hasan R, Ahmad I, Hendry D, Compérat EM, Burger M, Rouprêt M, Gontero P, Ribal MJ, van der Kwast TH, Babjuk M, Sylvester RJ, Mariappan P, Liedberg F, van Rhijn BWG; BladderBaSe-Consortium; Scot BC Quality OPS Collaborative; Multi-center EAU Non-Muscle-Invasive Bladder Cancer Guidelines Panel Study Consortium on the WHO1973; WHO2004/2016 Classification Systems for Grade. Beijert IJ, et al. Among authors: van rhijn bwg. Eur Urol. 2024 Nov;86(5):391-399. doi: 10.1016/j.eururo.2024.08.013. Epub 2024 Aug 29. Eur Urol. 2024. PMID: 39209674 Free article.

43

European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)-A Summary of the 2024 Guidelines Update.

Gontero P, Birtle A, Capoun O, Compérat E, Dominguez-Escrig JL, Liedberg F, Mariappan P, Masson-Lecomte A, Mostafid HA, Pradere B, Rai BP, van Rhijn BWG, Seisen T, Shariat SF, Soria F, Soukup V, Wood R, Xylinas EN. Gontero P, et al. Among authors: van rhijn bwg. Eur Urol. 2024 Dec;86(6):531-549. doi: 10.1016/j.eururo.2024.07.027. Epub 2024 Aug 17. Eur Urol. 2024. PMID: 39155194 Review.

44

Multi-Center Assessment of Lymph-Node Density and Nodal-Stage to Predict Disease-Specific Survival in Patients with Bladder Cancer Treated by Radical Cystectomy.

van Gennep EJ, Claps F, Bostrom PJ, Shariat SF, Neuzillet Y, Zlotta AR, Trombetta C, Eckstein M, Mertens LS, Bussani R, Burger M, Boormans JL, Wullich B, Hartmann A, Mayr R, Pavan N, Bartoletti R, Mir MC, Pouessel D, van der Hoeven J, van der Kwast TH, Allory Y, Zuiverloon TCM, Lotan Y, van Rhijn BWG. van Gennep EJ, et al. Among authors: van rhijn bwg. Bladder Cancer. 2024 Jun 18;10(2):119-132. doi: 10.3233/BLC-230086. eCollection 2024. Bladder Cancer. 2024. PMID: 39131875 Free PMC article.

45

The Prognostic Significance of Histological Subtypes in Patients with Muscle-Invasive Bladder Cancer: An Overview of the Current Literature.

Claps F, Biasatti A, Di Gianfrancesco L, Ongaro L, Giannarini G, Pavan N, Amodeo A, Simonato A, Crestani A, Cimadamore A, Hurle R, Mertens LS, van Rhijn BWG, Porreca A. Claps F, et al. Among authors: van rhijn bwg. J Clin Med. 2024 Jul 25;13(15):4349. doi: 10.3390/jcm13154349. J Clin Med. 2024. PMID: 39124615 Free PMC article. Review.

46

Platinum-Based Chemotherapy Induces Opposing Effects on Immunotherapy Response-Related Spatial and Stromal Biomarkers in the Bladder Cancer Microenvironment.

Chelushkin MA, van Dorp J, van Wilpe S, Seignette IM, Mellema JJ, Alkemade M, Gil-Jimenez A, Peters D, Brugman W, Stockem CF, Hooijberg E, Broeks A, van Rhijn BWG, Mertens LS, van der Heijden AG, Mehra N, van Montfoort ML, Wessels LFA, Vis DJ, van der Heijden MS. Chelushkin MA, et al. Among authors: van rhijn bwg. Clin Cancer Res. 2024 Sep 13;30(18):4227-4239. doi: 10.1158/1078-0432.CCR-24-0724. Clin Cancer Res. 2024. PMID: 39047168

47

Consistencies in Follow-up After Radical Cystectomy for Bladder Cancer: A Framework Based on Expert Practices Collaboratively Developed by the European Association of Urology Bladder Cancer Guideline Panels.

Mertens LS, Bruins HM, Contieri R, Babjuk M, Rai BP, Puig AC, Escrig JLD, Gontero P, van der Heijden AG, Liedberg F, Martini A, Masson-Lecomte A, Meijer RP, Mostafid H, Neuzillet Y, Pradere B, Redlef J, van Rhijn BWG, Rouanne M, Rouprêt M, Sæbjørnsen S, Seisen T, Shariat SF, Soria F, Soukup V, Thalmann G, Xylinas E, Mariappan P, Alfred Witjes J. Mertens LS, et al. Among authors: van rhijn bwg. Eur Urol Oncol. 2025 Feb;8(1):105-110. doi: 10.1016/j.euo.2024.05.010. Epub 2024 Jun 21. Eur Urol Oncol. 2025. PMID: 38906795

48

Variation in Follow-Up after Radical Cystectomy for Bladder Cancer-An Inventory Roundtable and Literature Review.

Contieri R, Pichler R, Del Giudice F, Marcq G, Gallioli A, Albisinni S, Soria F, d'Andrea D, Krajewski W, Carrion DM, Mari A, van Rhijn BWG, Moschini M, Pradere B, Mertens LS; EAU Young Academic Urologists Urothelial Cancer Working Group. Contieri R, et al. Among authors: van rhijn bwg. J Clin Med. 2024 Apr 30;13(9):2637. doi: 10.3390/jcm13092637. J Clin Med. 2024. PMID: 38731165 Free PMC article.

49

Spatial relationships in the urothelial and head and neck tumor microenvironment predict response to combination immune checkpoint inhibitors.

Gil-Jimenez A, van Dijk N, Vos JL, Lubeck Y, van Montfoort ML, Peters D, Hooijberg E, Broeks A, Zuur CL, van Rhijn BWG, Vis DJ, van der Heijden MS, Wessels LFA. Gil-Jimenez A, et al. Among authors: van rhijn bwg. Nat Commun. 2024 Mar 21;15(1):2538. doi: 10.1038/s41467-024-46450-1. Nat Commun. 2024. PMID: 38514623 Free PMC article.

50

Penile cancer care in the Netherlands: increased incidence, centralisation, and improved survival.

Vreeburg MTA, de Vries HM, van der Noort V, Horenblas S, van Rhijn BWG, Hendricksen K, Graafland N, van der Poel HG, Brouwer OR. Vreeburg MTA, et al. Among authors: van rhijn bwg. BJU Int. 2024 May;133(5):596-603. doi: 10.1111/bju.16306. Epub 2024 Feb 25. BJU Int. 2024. PMID: 38403729

51

Simulation of the effects of molecular urine markers in follow-up of patients with high-risk non-muscle invasive bladder cancer.

Benderska-Söder N, Ecke T, Kleinlein L, Roghmann F, Bismarck E, van Rhijn BWG, Stenzl A, Witjes JA, Todenhöfer T, Hakenberg OW, Grimm MO, Goebell PJ, Burger M, Jensen JB, Schmitz-Dräger BJ. Benderska-Söder N, et al. Among authors: van rhijn bwg. Urol Oncol. 2024 Aug;42(8):229-235. doi: 10.1016/j.urolonc.2024.01.025. Epub 2024 Feb 24. Urol Oncol. 2024. PMID: 38403529 Review.

52

The Financial Burden of Guideline-recommended Cancer Medications for Metastatic Urothelial Carcinoma.

Contieri R, Martini A, Mertens LS, Giannatempo P, Hurle R, Witjes JA, Ribal MJ, van Rhijn BWG, Malavaud B. Contieri R, et al. Among authors: van rhijn bwg. Eur Urol Focus. 2024 Jul;10(4):662-665. doi: 10.1016/j.euf.2023.12.002. Epub 2024 Jan 9. Eur Urol Focus. 2024. PMID: 38199886

53

Second TURB, restaging TURB or repeat TURB in primary T1 non-muscle invasive bladder cancer: impact on prognosis?

Beijert IJ, Hentschel AE, Bründl J, Compérat EM, Plass K, Rodríguez O, Subiela Henríquez JD, Hernández V, de la Peña E, Alemany I, Turturica D, Pisano F, Soria F, Čapoun O, Bauerová L, Pešl M, Bruins HM, Runneboom W, Herdegen S, Breyer J, Brisuda A, Calatrava A, Rubio-Briones J, Seles M, Mannweiler S, Bosschieter J, Kusuma VRM, Ashabere D, Huebner N, Cotte J, Contieri R, Mertens LS, Claps F, Masson-Lecomte A, Liedberg F, Cohen D, Lunelli L, Cussenot O, El Sheikh S, Volanis D, Côté JF, Rouprêt M, Haitel A, Shariat SF, Mostafid AH, Nieuwenhuijzen JA, Zigeuner R, Dominguez-Escrig JL, Hacek J, Zlotta AR, Burger M, Evert M, Hulsbergen-van de Kaa CA, van der Heijden AG, Kiemeney LALM, Soukup V, Molinaro L, Gontero P, Llorente C, Algaba F, Palou J, N'Dow J, Ribal MJ, van der Kwast TH, Babjuk M, Sylvester RJ, van Rhijn BWG. Beijert IJ, et al. Among authors: van rhijn bwg. Int Urol Nephrol. 2024 Apr;56(4):1323-1333. doi: 10.1007/s11255-023-03867-9. Epub 2023 Nov 19. Int Urol Nephrol. 2024. PMID: 37980689 Free article.

54

The effect of cisplatin-based neoadjuvant chemotherapy on the renal function of patients undergoing radical cystectomy.

Ho MD, Black AJ, Zargar H, Fairey AS, Mertens LS, Dinney CP, Mir MC, Krabbe LM, Cookson MS, Jacobsen NE, Montgomery JS, Yu EY, Xylinas E, Kassouf W, Dall'Era MA, Vasdev N, Sridhar SS, McGrath JS, Aning J, Holzbeierlein JM, Thorpe AC, Shariat SF, Wright JL, Morgan TM, Bivalacqua TJ, North S, Barocas DA, Lotan Y, Grivas P, Stephenson AJ, Shah JB, van Rhijn BW, Daneshmand S, Spiess PE, Black PC. Ho MD, et al. Among authors: van rhijn bw. Can Urol Assoc J. 2023 Oct;17(10):301-309. doi: 10.5489/cuaj.8570. Can Urol Assoc J. 2023. PMID: 37851909 Free PMC article.

55

Corrigendum to "Proposal for a Novel Histological Scoring System as a Potential Grading Approach for Muscle-invasive Urothelial Bladder Cancer Correlating with Disease Aggressiveness and Patient Outcomes" [European Urology Oncology (2023)].

Eckstein M, Matek C, Wagner P, Erber R, Büttner-Herold M, Wild PJ, Taubert H, Wach S, Sikic D, Wullich B, Geppert CI, Compérat EM, Lopez-Beltran A, Montironi R, Cheng L, van der Kwast T, Colecchia M, van Rhijn BWG, Amin MB, Netto GJ, Lehmann J, Stöckle M, Junker K, Hartmann A, Bertz S. Eckstein M, et al. Among authors: van rhijn bwg. Eur Urol Oncol. 2023 Dec;6(6):641. doi: 10.1016/j.euo.2023.09.023. Epub 2023 Oct 7. Eur Urol Oncol. 2023. PMID: 37813744 Free article. No abstract available.

56

Electronic health record and research; happy marriage or early divorce?

Scheltema MJ, van Rhijn BWG. Scheltema MJ, et al. Among authors: van rhijn bwg. BJU Int. 2024 Feb;133 Suppl 3:75. doi: 10.1111/bju.16194. Epub 2023 Oct 16. BJU Int. 2024. PMID: 37804138 No abstract available.

57

Induction therapy with ipilimumab and nivolumab followed by consolidative chemoradiation as organ-sparing treatment in urothelial bladder cancer: study protocol of the INDIBLADE trial.

Stockem CF, Mellema JJJ, van Rhijn BWG, Boellaard TN, van Montfoort ML, Balduzzi S, Boormans JL, Franckena M, Meijer RP, Robbrecht DGJ, Suelmann BBM, Schaake EE, van der Heijden MS. Stockem CF, et al. Among authors: van rhijn bwg. Front Oncol. 2023 Aug 29;13:1246603. doi: 10.3389/fonc.2023.1246603. eCollection 2023. Front Oncol. 2023. PMID: 37711193 Free PMC article.

58

The Diagnostic Accuracy of Cystoscopy for Detecting Bladder Cancer in Adults Presenting with Haematuria: A Systematic Review from the European Association of Urology Guidelines Office.

Devlies W, de Jong JJ, Hofmann F, Bruins HM, Zuiverloon TCM, Smith EJ, Yuan Y, van Rhijn BWG, Mostafid H, Santesso N, Violette P, Omar MI. Devlies W, et al. Among authors: van rhijn bwg. Eur Urol Focus. 2024 Jan;10(1):115-122. doi: 10.1016/j.euf.2023.08.002. Epub 2023 Aug 24. Eur Urol Focus. 2024. PMID: 37633791 Free article.

59

BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer: Current Treatment Landscape and Novel Emerging Molecular Targets.

Claps F, Pavan N, Ongaro L, Tierno D, Grassi G, Trombetta C, Tulone G, Simonato A, Bartoletti R, Mertens LS, van Rhijn BWG, Mir MC, Scaggiante B. Claps F, et al. Among authors: van rhijn bwg. Int J Mol Sci. 2023 Aug 9;24(16):12596. doi: 10.3390/ijms241612596. Int J Mol Sci. 2023. PMID: 37628785 Free PMC article. Review.

60

Proposal for a Novel Histological Scoring System as a Potential Grading Approach for Muscle-invasive Urothelial Bladder Cancer Correlating with Disease Aggressiveness and Patient Outcomes.

Eckstein M, Matek C, Wagner P, Erber R, Büttner-Herold M, Wild PJ, Taubert H, Wach S, Sikic D, Wullich B, Geppert CI, Compérat EM, Lopez-Beltran A, Montironi R, Cheng L, van der Kwast T, Colecchia M, van Rhijn BWG, Amin MB, Netto GJ, Lehmann J, Stöckle M, Junker K, Hartmann A, Bertz S. Eckstein M, et al. Among authors: van rhijn bwg. Eur Urol Oncol. 2024 Feb;7(1):128-138. doi: 10.1016/j.euo.2023.07.011. Epub 2023 Aug 8. Eur Urol Oncol. 2024. PMID: 37562993 Free article.

61

Atezolizumab With or Without Radiotherapy for Advanced Squamous Cell Carcinoma of the Penis (The PERICLES Study): A Phase II Trial.

de Vries HM, Rafael TS, Gil-Jimenez A, de Feijter JM, Bekers E, van der Laan E, Lopez-Yurda M, Hooijberg E, Broeks A, Peters D, Seignette IM, Pos FJ, Horenblas S, van Rhijn BWG, Jordanova ES, Brouwer OR, Schaake E, van der Heijden MS. de Vries HM, et al. Among authors: van rhijn bwg. J Clin Oncol. 2023 Nov 1;41(31):4872-4880. doi: 10.1200/JCO.22.02894. Epub 2023 Jul 24. J Clin Oncol. 2023. PMID: 37487169 Clinical Trial.

62

Author Correction: High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trial.

van Dorp J, Pipinikas C, Suelmann BBM, Mehra N, van Dijk N, Marsico G, van Montfoort ML, Hackinger S, Braaf LM, Amarante T, van Steenis C, McLay K, Daletzakis A, van den Broek D, van de Kamp MW, Hendricksen K, de Feijter JM, Boellaard TN, Meijer RP, van der Heijden AG, Rosenfeld N, van Rhijn BWG, Jones G, van der Heijden MS. van Dorp J, et al. Among authors: van rhijn bwg. Nat Med. 2024 Jan;30(1):304. doi: 10.1038/s41591-023-02500-7. Nat Med. 2024. PMID: 37460757 No abstract available.

63

Considering the Effects of Modern Point-of-Care Urine Biomarker Assays in Follow-Up of Patients with High-Risk Non-muscle-Invasive Bladder Cancer.

Ecke TH, Benderska-Söder N, Bismarck E, van Rhijn BWG, Todenhöfer T, Schmitz-Dräger BJ. Ecke TH, et al. Among authors: van rhijn bwg. Methods Mol Biol. 2023;2684:199-212. doi: 10.1007/978-1-0716-3291-8_12. Methods Mol Biol. 2023. PMID: 37410236

64

International Society of Urological Pathology (ISUP) Consensus Conference on Current Issues in Bladder Cancer. Working Group 2: Grading of Mixed Grade, Invasive Urothelial Carcinoma Including Histologic Subtypes and Divergent Differentiations, and Non-Urothelial Carcinomas.

Paner GP, Kamat A, Netto GJ, Samaratunga H, Varma M, Bubendorf L, van der Kwast TH, Cheng L; Members of the ISUP Bladder Tumor Consensus Panel. Paner GP, et al. Am J Surg Pathol. 2024 Jan 1;48(1):e11-e23. doi: 10.1097/PAS.0000000000002077. Epub 2023 Jun 29. Am J Surg Pathol. 2024. PMID: 37382156 Free article.

65

Stage-dependent survival in patients treated with neoadjuvant chemotherapy and radical cystectomy.

D'Andrea D, Shariat SF, Soria F, DI Trapani E, Mertens LS, VAN Rhijn BW, Dinney CP, Black PC, Spiess PE, Carrion DM, Pradere B, Tonin E, Pichler R, Filippot R, Mari A, Moschini M; European Association of Urology-Young Academic Urologists (EAU-YAU): Urothelial Carcinoma Working Group. D'Andrea D, et al. Among authors: van rhijn bw. Minerva Urol Nephrol. 2023 Aug;75(4):452-459. doi: 10.23736/S2724-6051.23.05289-8. Epub 2023 Jun 14. Minerva Urol Nephrol. 2023. PMID: 37314813 Free article.

66

International Opinions on Grading of Urothelial Carcinoma: A Survey Among European Association of Urology and International Society of Urological Pathology Members.

Beijert IJ, Cheng L, Liedberg F, Plass K, Williamson SR, Gontero P, Ribal MJ, Babjuk M, Black PC, Kamat AM, Algaba F, Berman DM, Hartmann A, Masson-Lecomte A, Rouprêt M, Lopez-Beltran A, Samaratunga H, Shariat SF, Mostafid AH, Varma M, Shen S, Burger M, Tsuzuki T, Palou J, Compérat EM, Sylvester RJ, van der Kwast TH, van Rhijn BWG, Downes MR. Beijert IJ, et al. Among authors: van rhijn bwg. Eur Urol Open Sci. 2023 May 10;52:154-165. doi: 10.1016/j.euros.2023.03.019. eCollection 2023 Jun. Eur Urol Open Sci. 2023. PMID: 37284047 Free PMC article.

67

Recent developments in perioperative combination therapy in muscle-invasive bladder cancer.

Mellema JJ, van Rhijn BWG, van der Heijden MS. Mellema JJ, et al. Among authors: van rhijn bwg. Curr Opin Urol. 2023 Sep 1;33(5):404-411. doi: 10.1097/MOU.0000000000001107. Epub 2023 Jun 2. Curr Opin Urol. 2023. PMID: 37265341 Review.

68

Low adherence to recommended use of neoadjuvant chemotherapy for muscle-invasive bladder cancer.

van Hoogstraten LMC, Man CCO, Witjes JA, Meijer RP, Mulder SF, Smilde TJ, Ripping TM, Kiemeney LA, Aben KKH; BlaZIB Study Group. van Hoogstraten LMC, et al. World J Urol. 2023 Jul;41(7):1837-1845. doi: 10.1007/s00345-023-04443-7. Epub 2023 May 31. World J Urol. 2023. PMID: 37258902 Free PMC article.

69

International Society of Urological Pathology (ISUP) Consensus Conference on Current Issues in Bladder Cancer. Working Group 1: Comparison of Bladder Cancer Grading System Performance.

Downes MR, Hartmann A, Shen S, Tsuzuki T, van Rhijn BWG, Bubendorf L, van der Kwast TH, Cheng L; Members of the ISUP Bladder Tumor Consensus Panel. Downes MR, et al. Among authors: van rhijn bwg. Am J Surg Pathol. 2024 Jan 1;48(1):e1-e10. doi: 10.1097/PAS.0000000000002059. Epub 2023 May 29. Am J Surg Pathol. 2024. PMID: 37246824

70

Staging fluorodeoxyglucose positron emission tomography/computed tomography for muscle-invasive bladder cancer: a nationwide population-based study.

Richters A, van Ginkel N, Meijer RP, Wondergem M, Schoots I, Vis AN, Kiemeney LALM, van Rhijn BWG, Witjes JA, Aben KKH, Mertens LS. Richters A, et al. Among authors: van rhijn bwg. BJU Int. 2023 Oct;132(4):420-427. doi: 10.1111/bju.16091. Epub 2023 Jun 15. BJU Int. 2023. PMID: 37246479

71

The Utility of Inflammatory Serum Markers in the Assessment of Perioperative Morbidity after Radical Cystectomy for Bladder Cancer.

Claps F, Rossin G, van Rhijn BWG, Mir MC, Mertens LS, Ongaro L, Traunero F, Iachimovsky AI, Piasentin A, Vedovo F, Perotti A, Tulone G, Zucchi A, Liguori G, Simonato A, Bartoletti R, Trombetta C, Pavan N. Claps F, et al. Among authors: van rhijn bwg. Medicina (Kaunas). 2023 May 11;59(5):926. doi: 10.3390/medicina59050926. Medicina (Kaunas). 2023. PMID: 37241158 Free PMC article.

72

The Implementation of FDG PET/CT for Staging Bladder Cancer: Changes in the Detection and Characteristics of Occult Nodal Metastases at Upfront Radical Cystectomy?

Einerhand SMH, Zuur LG, Wondergem MJ, Boellaard TN, Barwari K, van Leeuwen PJ, van Rhijn BWG, Mertens LS. Einerhand SMH, et al. Among authors: van rhijn bwg. J Clin Med. 2023 May 9;12(10):3367. doi: 10.3390/jcm12103367. J Clin Med. 2023. PMID: 37240473 Free PMC article.

73

International Society of Urological Pathology Consensus Conference on Current Issues in Bladder Cancer. Working Group 4: Molecular Subtypes of Bladder Cancer-Principles of Classification and Emerging Clinical Utility.

Warrick JI, Al-Ahmadie H, Berman DM, Black PC, Flaig TW, Höglund M, Bubendorf L, van der Kwast TH, Cheng L; Members of the ISUP Bladder Tumor Consensus Panel. Warrick JI, et al. Am J Surg Pathol. 2024 Jan 1;48(1):e32-e42. doi: 10.1097/PAS.0000000000002053. Epub 2023 May 18. Am J Surg Pathol. 2024. PMID: 37199442 Free article. Review.

74

Carboplatin Induction Chemotherapy in Clinically Lymph Node-positive Bladder Cancer.

von Deimling M, Mertens LS, van Rhijn BWG, Lotan Y, Spiess PE, Daneshmand S, Black PC, Pallauf M, D'Andrea D, Moschini M, Soria F, Del Giudice F, Afferi L, Laukhtina E, Yanagisawa T, Kawada T, Teoh JY, Abufaraj M, Ploussard G, Roumiguié M, Karakiewicz PI, Babjuk M, Gontero P, Xylinas E, Rink M, Shariat SF, Pradere B. von Deimling M, et al. Among authors: van rhijn bwg. Eur Urol Open Sci. 2023 Mar 25;51:39-46. doi: 10.1016/j.euros.2023.02.014. eCollection 2023 May. Eur Urol Open Sci. 2023. PMID: 37187719 Free PMC article.

75

Prospective Evaluation of FDG-PET/CT for On-treatment Assessment of Response to Neoadjuvant or Induction Chemotherapy in Invasive Bladder Cancer.

Einerhand SMH, Voskuilen CS, van de Putte EEF, Donswijk ML, Bruining A, van der Heijden MS, Mertens LS, Hendricksen K, Vegt E, van Rhijn BWG. Einerhand SMH, et al. Among authors: van rhijn bwg. Bladder Cancer. 2023 Mar 31;9(1):49-57. doi: 10.3233/BLC-220036. eCollection 2023. Bladder Cancer. 2023. PMID: 38994487 Free PMC article.

76

Body Composition of Patients Undergoing Radical Cystectomy for Bladder Cancer: Sarcopenia, Low Psoas Muscle Index, and Myosteatosis Are Independent Risk Factors for Mortality.

Engelmann SU, Pickl C, Haas M, Kaelble S, Hartmann V, Firsching M, Lehmann L, Gužvić M, van Rhijn BWG, Breyer J, Burger M, Mayr R. Engelmann SU, et al. Among authors: van rhijn bwg. Cancers (Basel). 2023 Mar 15;15(6):1778. doi: 10.3390/cancers15061778. Cancers (Basel). 2023. PMID: 36980664 Free PMC article.

77

European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2023 Update.

Rouprêt M, Seisen T, Birtle AJ, Capoun O, Compérat EM, Dominguez-Escrig JL, Gürses Andersson I, Liedberg F, Mariappan P, Hugh Mostafid A, Pradere B, van Rhijn BWG, Shariat SF, Rai BP, Soria F, Soukup V, Wood RG, Xylinas EN, Masson-Lecomte A, Gontero P. Rouprêt M, et al. Among authors: van rhijn bwg. Eur Urol. 2023 Jul;84(1):49-64. doi: 10.1016/j.eururo.2023.03.013. Epub 2023 Mar 24. Eur Urol. 2023. PMID: 36967359 Review.

78

Added Clinical Value of ¹⁸F-FDG-PET/CT to Stage Patients With High-Risk Non-Muscle Invasive Bladder Cancer Before Radical Cystectomy.

van Ginkel N, van Gennep EJ, Oosterbaan L, Greidanus J, Boellaard TN, Wondergem M, Vis AN, de Reijke TM, van Rhijn BWG, Mertens LS. van Ginkel N, et al. Among authors: van rhijn bwg. Clin Genitourin Cancer. 2023 Jun;21(3):342-348. doi: 10.1016/j.clgc.2023.02.004. Epub 2023 Feb 22. Clin Genitourin Cancer. 2023. PMID: 36918302

79

Corrigendum to "Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer" [Eur Urol 2023;83:313-17].

Gil-Jimenez A, van Dorp J, Contreras-Sanz A, van der Vos K, Vis DJ, Braaf L, Broeks A, Kerkhoven R, van Kessel KEM, Ribal MJ, Alcaraz A, Wessels LFA, Seiler R, Wright JL, Mengual L, Boormans J, van Rhijn BWG, Black PC, van der Heijden MS. Gil-Jimenez A, et al. Among authors: van rhijn bwg. Eur Urol. 2023 Jun;83(6):e165. doi: 10.1016/j.eururo.2023.03.002. Epub 2023 Mar 10. Eur Urol. 2023. PMID: 36907692 No abstract available.

80

Erratum to "European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel" [Eur. Urol. 79(4) (2021) 480-488].

Sylvester RJ, Rodríguez O, Hernández V, Turturica D, Bauerová L, Max Bruins H, Bründl J, van der Kwast TH, Brisuda A, Rubio-Briones J, Seles M, Hentschel AE, Kusuma VRM, Huebner N, Cotte J, Mertens LS, Volanis D, Cussenot O, Subiela Henríquez JD, de la Peña E, Pisano F, Pešl M, van der Heijden AG, Herdegen S, Zlotta AR, Hacek J, Calatrava A, Mannweiler S, Bosschieter J, Ashabere D, Haitel A, Côté JF, El Sheikh S, Lunelli L, Algaba F, Alemany I, Soria F, Runneboom W, Breyer J, Nieuwenhuijzen JA, Llorente C, Molinaro L, Hulsbergen-van de Kaa CA, Evert M, Kiemeney LALM, N'Dow J, Plass K, Čapoun O, Soukup V, Dominguez-Escrig JL, Cohen D, Palou J, Gontero P, Burger M, Zigeuner R, Mostafid AH, Shariat SF, Rouprêt M, Compérat EM, Babjuk M, van Rhijn BWG. Sylvester RJ, et al. Among authors: van rhijn bwg. Eur Urol. 2023 May;83(5):e140-e141. doi: 10.1016/j.eururo.2023.02.007. Epub 2023 Feb 24. Eur Urol. 2023. PMID: 36841687 No abstract available.

81

Clinical value of preoperative serum tumor markers CEA, CA19-9, CA125, and CA15-3 in surgically treated urachal cancer.

Stokkel LE, van Rossum HH, van de Kamp MW, Boellaard TN, Bekers EM, Kok NFM, van Rhijn BWG, Mertens LS. Stokkel LE, et al. Among authors: van rhijn bwg. Urol Oncol. 2023 Jul;41(7):326.e17-326.e24. doi: 10.1016/j.urolonc.2023.01.018. Epub 2023 Feb 21. Urol Oncol. 2023. PMID: 36813613

82

Impact of Maximal Transurethral Resection on Pathological Outcomes at Cystectomy in a Large, Multi-institutional Cohort.

Kirk PS, Lotan Y, Zargar H, Fairey AS, Dinney CP, Mir MC, Krabbe LM, Cookson MS, Jacobson NE, Montgomery JS, Vasdev N, Yu EY, Xylinas E, Kassouf W, Dall'Era MA, Sridhar SS, McGrath JS, Aning J, Shariat SF, Thorpe AC, Morgan TM, Holzbeierlein JM, Bivalacqua TJ, North S, Barocas DA, Grivas P, Garcia JA, Stephenson AJ, Shah JB, Daneshmand S, Spiess PE, van Rhijn BWG, Mertens L, Black P, Wright JL. Kirk PS, et al. Among authors: van rhijn bwg. J Urol. 2023 May;209(5):882-889. doi: 10.1097/JU.0000000000003193. Epub 2023 Feb 16. J Urol. 2023. PMID: 36795962

83

Bladder Recurrence Following Upper Tract Surgery for Urothelial Carcinoma: A Contemporary Review of Risk Factors and Management Strategies.

Mertens LS, Sharma V, Matin SF, Boorjian SA, Houston Thompson R, van Rhijn BWG, Masson-Lecomte A. Mertens LS, et al. Among authors: van rhijn bwg. Eur Urol Open Sci. 2023 Jan 28;49:60-66. doi: 10.1016/j.euros.2023.01.004. eCollection 2023 Mar. Eur Urol Open Sci. 2023. PMID: 36793750 Free PMC article. Review.

84

Prognostic impact of variant histologies in urothelial bladder cancer treated with radical cystectomy.

Claps F, van de Kamp MW, Mayr R, Bostrom PJ, Shariat SF, Hippe K, Bertz S, Neuzillet Y, Sanders J, Otto W, van der Heijden MS, Jewett MAS, Stöhr R, Zlotta AR, Trombetta C, Eckstein M, Mertens LS, Burger M, Soorojebally Y, Wullich B, Bartoletti R, Radvanyi F, Pavan N, Sirab N, Mir MC, Pouessel D, van der Kwast TH, Hartmann A, Lotan Y, Bussani R, Allory Y, van Rhijn BWG. Claps F, et al. Among authors: van rhijn bwg. BJU Int. 2023 Aug;132(2):170-180. doi: 10.1111/bju.15984. Epub 2023 Feb 20. BJU Int. 2023. PMID: 36748180 Free article.

85

High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trial.

van Dorp J, Pipinikas C, Suelmann BBM, Mehra N, van Dijk N, Marsico G, van Montfoort ML, Hackinger S, Braaf LM, Amarante T, van Steenis C, McLay K, Daletzakis A, van den Broek D, van de Kamp MW, Hendricksen K, de Feijter JM, Boellaard TN, Meijer RP, van der Heijden AG, Rosenfeld N, van Rhijn BWG, Jones G, van der Heijden MS. van Dorp J, et al. Among authors: van rhijn bwg. Nat Med. 2023 Mar;29(3):588-592. doi: 10.1038/s41591-022-02199-y. Epub 2023 Feb 2. Nat Med. 2023. PMID: 36732628 Clinical Trial.

86

Body Composition as a Comorbidity-Independent Predictor of Survival following Nephroureterectomy for Urothelial Cancer of the Upper Urinary Tract.

Pickl C, Engelmann S, Girtner F, Gužvić M, van Rhijn BWG, Hartmann V, Holbach S, Kälble S, Haas M, Rosenhammer B, Breyer J, Burger M, Mayr R. Pickl C, et al. Among authors: van rhijn bwg. Cancers (Basel). 2023 Jan 10;15(2):450. doi: 10.3390/cancers15020450. Cancers (Basel). 2023. PMID: 36672398 Free PMC article.

87

Prognosis of Primary Papillary Ta Grade 3 Bladder Cancer in the Non-muscle-invasive Spectrum.

Beijert IJ, Hentschel AE, Bründl J, Compérat EM, Plass K, Rodríguez O, Subiela Henríquez JD, Hernández V, de la Peña E, Alemany I, Turturica D, Pisano F, Soria F, Čapoun O, Bauerová L, Pešl M, Bruins HM, Runneboom W, Herdegen S, Breyer J, Brisuda A, Calatrava A, Rubio-Briones J, Seles M, Mannweiler S, Bosschieter J, Kusuma VRM, Ashabere D, Huebner N, Cotte J, Mertens LS, Claps F, Masson-Lecomte A, Liedberg F, Cohen D, Lunelli L, Cussenot O, El Sheikh S, Volanis D, Côté JF, Rouprêt M, Haitel A, Shariat SF, Mostafid AH, Nieuwenhuijzen JA, Zigeuner R, Dominguez-Escrig JL, Hacek J, Zlotta AR, Burger M, Evert M, Hulsbergen-van de Kaa CA, van der Heijden AG, Kiemeney LALM, Soukup V, Molinaro L, Gontero P, Llorente C, Algaba F, Palou J, N'Dow J, Ribal MJ, van der Kwast TH, Babjuk M, Sylvester RJ, van Rhijn BWG. Beijert IJ, et al. Among authors: van rhijn bwg. Eur Urol Oncol. 2023 Apr;6(2):214-221. doi: 10.1016/j.euo.2023.01.004. Epub 2023 Jan 18. Eur Urol Oncol. 2023. PMID: 36670042 Free article.

88

Patterns of Recurrence and Survival After Pelvic Treatment for Locally Advanced Penile Cancer.

de Vries HM, Ottenhof SR, Rafael TS, van Werkhoven E, Pos FJ, van Rhijn BWG, Moonen LMF, Graafland N, de Feijter JM, Schaake EE, Horenblas S, Brouwer OR. de Vries HM, et al. Among authors: van rhijn bwg. Eur Urol Open Sci. 2022 Dec 15;47:29-35. doi: 10.1016/j.euros.2022.11.005. eCollection 2023 Jan. Eur Urol Open Sci. 2022. PMID: 36601037 Free PMC article.

89

Validation and reliability of the Dutch version of the EORTC QLQ-BLM30 module for assessing the health-related quality of life of patients with muscle invasive bladder cancer.

Ripping TM, Rammant E, Witjes JA, Aaronson NK, van Hemelrijck M, van Hoogstraten LMC; BlaZIB study group; Kiemeney LA, Aben KKH. Ripping TM, et al. Health Qual Life Outcomes. 2022 Dec 29;20(1):171. doi: 10.1186/s12955-022-02064-z. Health Qual Life Outcomes. 2022. PMID: 36581934 Free PMC article.

90

Impact of the controlling nutritional status (CONUT) score on perioperative morbidity and oncological outcomes in patients with bladder cancer treated with radical cystectomy.

Claps F, Mir MC, van Rhijn BWG, Mazzon G, Soria F, D'Andrea D, Marra G, Boltri M, Traunero F, Massanova M, Liguori G, Dominguez-Escrig JL, Celia A, Gontero P, Shariat SF, Trombetta C, Pavan N. Claps F, et al. Among authors: van rhijn bwg. Urol Oncol. 2023 Jan;41(1):49.e13-49.e22. doi: 10.1016/j.urolonc.2022.09.023. Epub 2022 Oct 21. Urol Oncol. 2023. PMID: 36274030 Free article.

91

Re: Neoadjuvant PD-L1 plus CTLA-4 Blockade in Patients with Cisplatin-ineligible Operable High-risk Urothelial Carcinoma.

Einerhand SMH, van Dorp J, van der Heijden MS, van Rhijn BWG. Einerhand SMH, et al. Among authors: van rhijn bwg. Eur Urol. 2023 Jan;83(1):91-92. doi: 10.1016/j.eururo.2022.09.024. Epub 2022 Oct 7. Eur Urol. 2023. PMID: 36210214 No abstract available.

92

Multicenter evaluation of neoadjuvant and induction gemcitabine-carboplatin versus gemcitabine-cisplatin followed by radical cystectomy for muscle-invasive bladder cancer.

Einerhand SMH, Black AJ, Zargar H, Fairey AS, Dinney CP, Mir MC, Krabbe LM, Cookson MS, Jacobson NE, Montgomery JS, Vasdev N, Yu EY, Xylinas E, Kassouf W, Dall'Era MA, Sridhar SS, McGrath JS, Aning J, Shariat SF, Wright JL, Thorpe AC, Morgan TM, Holzbeierlein JM, Bivalacqua TJ, North S, Barocas DA, Lotan Y, Grivas P, Garcia JA, Stephenson AJ, Shah JB, Daneshmand S, Zargar-Shoshtari K, Spiess PE, van Rhijn BWG, Black PC, Mertens LS. Einerhand SMH, et al. Among authors: van rhijn bwg. World J Urol. 2022 Nov;40(11):2707-2715. doi: 10.1007/s00345-022-04160-7. Epub 2022 Sep 28. World J Urol. 2022. PMID: 36169695 Free PMC article.

93

Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer.

Gil-Jimenez A, van Dorp J, Contreras-Sanz A, van der Vos K, Vis DJ, Braaf L, Broeks A, Kerkhoven R, van Kessel KEM, Ribal MJ, Alcaraz A, Wessels LFA, Seiler R, Wright JL, Mengual L, Boormans J, van Rhijn BWG, Black PC, van der Heijden MS. Gil-Jimenez A, et al. Among authors: van rhijn bwg. Eur Urol. 2023 Apr;83(4):313-317. doi: 10.1016/j.eururo.2022.07.023. Epub 2022 Aug 11. Eur Urol. 2023. PMID: 35965206

94

The influence of multidisciplinary team meetings on treatment decisions in advanced bladder cancer.

Walraven JEW, Ripping TM, Oddens JR, van Rhijn BWG, Goossens-Laan CA, Hulshof MCCM; BlaZIB Study Group; Kiemeney LA, Witjes JA, Lemmens VEPP, van der Hoeven JJM, Desar IME, Aben KKH, Verhoeven RHA. Walraven JEW, et al. Among authors: van rhijn bwg. BJU Int. 2023 Feb;131(2):244-252. doi: 10.1111/bju.15856. Epub 2022 Aug 5. BJU Int. 2023. PMID: 35861125 Free PMC article.

95

Reply to: Comments on "Neoadjuvant/induction combination immunotherapy vs combination platinum-based chemotherapy for locally advanced (Stage III) urothelial cancer".

Einerhand SMH, van Dijk N, van der Heijden MS, van Rhijn BWG. Einerhand SMH, et al. Among authors: van rhijn bwg. Int J Cancer. 2022 Nov 15;151(10):1849-1850. doi: 10.1002/ijc.34207. Epub 2022 Aug 10. Int J Cancer. 2022. PMID: 35815942 No abstract available.

96

The Impact of Primary Versus Secondary Muscle-invasive Bladder Cancer at Diagnosis on the Response to Neoadjuvant Chemotherapy.

D'Andrea D, Shariat SF, Soria F, Mari A, Mertens LS, Di Trapani E, Carrion DM, Pradere B, Pichler R, Filippot R, Grisay G, Del Giudice F, Laukhtina E, Paulnsteiner D, Krajewski W, Vallet S, Maggi M, De Berardinis E, Álvarez-Maestro M, Brönimann S, Di Maida F, van Rhijn BWG, Hendricksen K, Moschini M; European Association of Urology Young Academic Urologists Urothelial Carcinoma Working Group. D'Andrea D, et al. Among authors: van rhijn bwg. Eur Urol Open Sci. 2022 May 28;41:74-80. doi: 10.1016/j.euros.2022.05.001. eCollection 2022 Jul. Eur Urol Open Sci. 2022. PMID: 35813257 Free PMC article.

97

Evaluation of the Hybrid Tracer Indocyanine Green- 99m Tc-Nanocolloid for Sentinel Node Biopsy in Bladder Cancer-A Prospective Pilot Study.

Rietbergen DDD, van Gennep EJ, KleinJan GH, Donswijk M, Valdés Olmos RA, van Rhijn BW, van der Poel HG, van Leeuwen FWB. Rietbergen DDD, et al. Among authors: van rhijn bw. Clin Nucl Med. 2022 Sep 1;47(9):774-780. doi: 10.1097/RLU.0000000000004301. Epub 2022 Jun 18. Clin Nucl Med. 2022. PMID: 35713891 Free PMC article.

98

Corrigendum to: Mechanistic target of rapamycin (mTOR) protein expression in the tumor and its microenvironment correlates with more aggressive pathology at cystectomy.

Winters BR, Vakar-Lopez F, Brown L, Montgomery B, Seilerd R, Black PC, Boormans JL, Dall'Era M, Davincioni E, Douglas J, Gibb EA, van Rhijn BWG, van der Heijden MS, Hsiehc AC, Wrighta JL, Lam HM. Winters BR, et al. Among authors: van rhijn bwg. Urol Oncol. 2022 Jul;40(7):352. doi: 10.1016/j.urolonc.2022.05.011. Epub 2022 May 28. Urol Oncol. 2022. PMID: 35641377 No abstract available.

99

Survival after neoadjuvant/induction combination immunotherapy vs combination platinum-based chemotherapy for locally advanced (Stage III) urothelial cancer.

Einerhand SMH, van Dijk N, van Dorp J, de Feijter JM, van Montfoort ML, van de Kamp MW, Schaake EE, Boellaard TN, Hendricksen K, van der Heijden MS, van Rhijn BWG. Einerhand SMH, et al. Among authors: van rhijn bwg. Int J Cancer. 2022 Dec 1;151(11):2004-2011. doi: 10.1002/ijc.34125. Epub 2022 Jun 10. Int J Cancer. 2022. PMID: 35603905 Clinical Trial.

100

T1G1 Bladder Cancer: Prognosis for this Rare Pathological Diagnosis Within the Non-muscle-invasive Bladder Cancer Spectrum.

Beijert IJ, Hentschel AE, Bründl J, Compérat EM, Plass K, Rodríguez O, Subiela Henríquez JD, Hernández V, de la Peña E, Alemany I, Turturica D, Pisano F, Soria F, Čapoun O, Bauerová L, Pešl M, Maxim Bruins H, Runneboom W, Herdegen S, Breyer J, Brisuda A, Calatrava A, Rubio-Briones J, Seles M, Mannweiler S, Bosschieter J, Kusuma VRM, Ashabere D, Huebner N, Cotte J, Mertens LS, Masson-Lecomte A, Liedberg F, Cohen D, Lunelli L, Cussenot O, El Sheikh S, Volanis D, Côté JF, Rouprêt M, Haitel A, Shariat SF, Mostafid AH, Nieuwenhuijzen JA, Zigeuner R, Dominguez-Escrig JL, Hacek J, Zlotta AR, Burger M, Evert M, Hulsbergen-van de Kaa CA, van der Heijden AG, A L M Kiemeney L, Soukup V, Molinaro L, Gontero P, Llorente C, Algaba F, Palou J, N'Dow J, Ribal MJ, van der Kwast TH, Babjuk M, Sylvester RJ, van Rhijn BWG. Beijert IJ, et al. Among authors: van rhijn bwg. Eur Urol Focus. 2022 Nov;8(6):1627-1634. doi: 10.1016/j.euf.2022.04.014. Epub 2022 May 14. Eur Urol Focus. 2022. PMID: 35577750

101

Comparative Outcomes of Primary Versus Recurrent High-risk Non-muscle-invasive and Primary Versus Secondary Muscle-invasive Bladder Cancer After Radical Cystectomy: Results from a Retrospective Multicenter Study.

Grossmann NC, Rajwa P, Quhal F, König F, Mostafaei H, Laukhtina E, Mori K, Katayama S, Motlagh RS, Fankhauser CD, Mattei A, Moschini M, Chlosta P, van Rhijn BWG, Teoh JYC, Compérat E, Babjuk M, Abufaraj M, Karakiewicz PI, Shariat SF, Pradere B. Grossmann NC, et al. Among authors: van rhijn bwg. Eur Urol Open Sci. 2022 Apr 1;39:14-21. doi: 10.1016/j.euros.2022.02.011. eCollection 2022 May. Eur Urol Open Sci. 2022. PMID: 35528782 Free PMC article.

102

The Search for the Optimal cut-off Value of p53-Immunohistochemistry to Predict Prognosis of Invasive Bladder Cancer: A Multi-Center, Multi-Laboratory Analysis.

Mertens LS, Claps F, Mayr R, Hodgson A, Shariat SF, Hippe K, Neuzillet Y, Sanders J, Burger M, Pouessel D, Otto W, van der Kwast TH, Lotan Y, Allory Y, Downes MR, van Rhijn BWG. Mertens LS, et al. Among authors: van rhijn bwg. Int J Surg Pathol. 2023 Apr;31(2):157-166. doi: 10.1177/10668969221095173. Epub 2022 Apr 24. Int J Surg Pathol. 2023. PMID: 35466737 Free article.

103

Systematic Review of the Incidence of and Risk Factors for Urothelial Cancers and Renal Cell Carcinoma Among Patients with Haematuria.

Rai BP, Luis Dominguez Escrig J, Vale L, Kuusk T, Capoun O, Soukup V, Bruins HM, Yuan Y, Violette PD, Santesso N, van Rhijn BWG, Hugh Mostafid A, Imran Omar M. Rai BP, et al. Among authors: van rhijn bwg. Eur Urol. 2022 Aug;82(2):182-192. doi: 10.1016/j.eururo.2022.03.027. Epub 2022 Apr 5. Eur Urol. 2022. PMID: 35393159

104

Sensitivity and Specificity in Urine Bladder Cancer Markers - Is it that Simple?

Roghmann F, Goebell PJ, Dyrskjøt L, van Rhijn BWG, Käfferlein HU, Hakenberg O, Stenzl A, Burger M, Pesch B, Benderska-Söder N, Schmitz-Dräger BJ. Roghmann F, et al. Among authors: van rhijn bwg. Bladder Cancer. 2022 Mar 11;8(1):1-4. doi: 10.3233/BLC-211602. eCollection 2022. Bladder Cancer. 2022. PMID: 38994515 Free PMC article.

105

Corrigendum to "Nomogram Predicting Bladder Cancer-specific Mortality After Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-invasive Bladder Cancer: Results of an International Consortium" [Eur Urol Focus 2021;7:1347-54].

Mir MC, Marchioni M, Zargar H, Zargar-Shoshtari K, Fairey AS, Mertens LS, Dinney CP, Krabbe LM, Cookson MS, Jacobsen NE, Griffin J, Montgomery JS, Vasdev N, Yu EY, Xylinas E, McGrath JS, Kassouf W, Dall'Era MA, Sridhar SS, Aning J, Shariat SF, Wright JL, Thorpe AC, Morgan TM, Holzbeierlein JM, Bivalacqua TJ, North S, Barocas DA, Lotan Y, Grivas P, Stephenson AJ, Shah JB, van Rhijn BW, Spiess PE, Daneshmand S, Black PC. Mir MC, et al. Among authors: van rhijn bw. Eur Urol Focus. 2022 Sep;8(5):1559. doi: 10.1016/j.euf.2022.01.009. Epub 2022 Feb 15. Eur Urol Focus. 2022. PMID: 35181282 No abstract available.

106

Robot-Assisted Partial Cystectomy versus Open Partial Cystectomy for Patients with Urachal Cancer.

Stokkel LE, van de Kamp MW, Schaake EE, Boellaard TN, Hendricksen K, van Rhijn BWG, Mertens LS. Stokkel LE, et al. Among authors: van rhijn bwg. Urol Int. 2022;106(8):840-847. doi: 10.1159/000521605. Epub 2022 Feb 8. Urol Int. 2022. PMID: 35134799

107

A Serendipitous Preoperative Trial of Combined Ipilimumab Plus Nivolumab for Localized Prostate Cancer.

van Dorp J, van Montfoort ML, van Dijk N, Hofland I, de Feijter JM, Bergman AM, Hendricksen K, van der Poel HG, van Rhijn BWG, van der Heijden MS. van Dorp J, et al. Among authors: van rhijn bwg. Clin Genitourin Cancer. 2022 Apr;20(2):e173-e179. doi: 10.1016/j.clgc.2021.12.004. Epub 2021 Dec 10. Clin Genitourin Cancer. 2022. PMID: 35016887 No abstract available.

108

The Tumor Immune Landscape and Architecture of Tertiary Lymphoid Structures in Urothelial Cancer.

van Dijk N, Gil-Jimenez A, Silina K, van Montfoort ML, Einerhand S, Jonkman L, Voskuilen CS, Peters D, Sanders J, Lubeck Y, Broeks A, Hooijberg E, Vis DJ, van den Broek M, Wessels LFA, van Rhijn BWG, van der Heijden MS. van Dijk N, et al. Among authors: van rhijn bwg. Front Immunol. 2021 Dec 20;12:793964. doi: 10.3389/fimmu.2021.793964. eCollection 2021. Front Immunol. 2021. PMID: 34987518 Free PMC article. Clinical Trial.

109

Prognostic markers in invasive bladder cancer: FGFR3 mutation status versus P53 and KI-67 expression: a multi-center, multi-laboratory analysis in 1058 radical cystectomy patients.

Mertens LS, Claps F, Mayr R, Bostrom PJ, Shariat SF, Zwarthoff EC, Boormans JL, Abas C, van Leenders GJLH, Götz S, Hippe K, Bertz S, Neuzillet Y, Sanders J, Broeks A, Peters D, van der Heijden MS, Jewett MAS, Stöhr R, Zlotta AR, Eckstein M, Soorojebally Y, van der Schoot DKE, Wullich B, Burger M, Otto W, Radvanyi F, Sirab N, Pouessel D, van der Kwast TH, Hartmann A, Lotan Y, Allory Y, Zuiverloon TCM, van Rhijn BWG. Mertens LS, et al. Among authors: van rhijn bwg. Urol Oncol. 2022 Mar;40(3):110.e1-110.e9. doi: 10.1016/j.urolonc.2021.10.010. Epub 2021 Dec 11. Urol Oncol. 2022. PMID: 34906411 Free article.

110

Two Patients with Urachal Cancer with Multifocal Adenocarcinoma Recurrences in the Urothelium of the Prostatic and Penile Urethra.

Stokkel LE, van Montfoort ML, van Boven HH, Mertens LS, van Rhijn BWG. Stokkel LE, et al. Among authors: van rhijn bwg. Eur Urol Open Sci. 2021 Sep 24;33:56-60. doi: 10.1016/j.euros.2021.08.010. eCollection 2021 Nov. Eur Urol Open Sci. 2021. PMID: 34622223 Free PMC article.

111

Occult lymph node metastases in patients without residual muscle-invasive bladder cancer at radical cystectomy with or without neoadjuvant chemotherapy: a nationwide study of 5417 patients.

van Hoogstraten LMC, van Gennep EJ, Kiemeney LALM, Witjes JA, Voskuilen CS, Deelen M, Mertens LS, Meijer RP, Boormans JL, Robbrecht DGJ, Beerepoot LV, Verhoeven RHA, Ripping TM; BlaZIB Study Group; van Rhijn BWG, Aben KKH, Hermans TJN. van Hoogstraten LMC, et al. Among authors: van rhijn bwg. World J Urol. 2022 Jan;40(1):111-118. doi: 10.1007/s00345-021-03839-7. Epub 2021 Sep 28. World J Urol. 2022. PMID: 34585294 Free PMC article.

112

European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ).

Babjuk M, Burger M, Capoun O, Cohen D, Compérat EM, Dominguez Escrig JL, Gontero P, Liedberg F, Masson-Lecomte A, Mostafid AH, Palou J, van Rhijn BWG, Rouprêt M, Shariat SF, Seisen T, Soukup V, Sylvester RJ. Babjuk M, et al. Among authors: van rhijn bwg. Eur Urol. 2022 Jan;81(1):75-94. doi: 10.1016/j.eururo.2021.08.010. Epub 2021 Sep 10. Eur Urol. 2022. PMID: 34511303 Review.

113

Identifying the Optimal Number of Neoadjuvant Chemotherapy Cycles in Patients with Muscle Invasive Bladder Cancer.

D'Andrea D, Black PC, Zargar H, Dinney CP, Soria F, Cookson MS, Montgomery JS, Kassouf W, Dall'Era MA, Sridhar SS, McGrath JS, Wright JL, Thorpe AC, Holzbeierlein JM, Carrión DM, Di Trapani E, Bivalacqua TJ, North S, Barocas DA, Lotan Y, Grivas P, Stephenson AJ, van Rhijn BW, Daneshmand S, Spiess PE, Shariat SF; Contributors. D'Andrea D, et al. Among authors: van rhijn bw. J Urol. 2022 Jan;207(1):70-76. doi: 10.1097/JU.0000000000002190. Epub 2021 Aug 27. J Urol. 2022. PMID: 34445891

114

Association of age with response to preoperative chemotherapy in patients with muscle-invasive bladder cancer.

D'Andrea D, Black PC, Zargar H, Zargar-Shoshtari K, Soria F, Fairey AS, Mertens LS, Dinney CP, Mir MC, Krabbe LM, Cookson MS, Jacobsen NE, Montgomery JS, Vasdev N, Yu EY, Xylinas E, Campain NJ, Kassouf W, Dall'Era MA, Seah JA, Ercole CE, Horenblas S, Sridhar SS, McGrath JS, Aning J, Wright JL, Thorpe AC, Morgan TM, Holzbeierlein JM, Bivalacqua TJ, North S, Barocas DA, Lotan Y, Grivas P, Stephenson AJ, Shah JB, van Rhijn BW, Daneshmand S, Spiess PE, Shariat SF. D'Andrea D, et al. Among authors: van rhijn bw. World J Urol. 2021 Dec;39(12):4345-4354. doi: 10.1007/s00345-021-03793-4. Epub 2021 Aug 9. World J Urol. 2021. PMID: 34370078 Free PMC article.

115

Risk factors associated with positive surgical margins' location at radical cystectomy and their impact on bladder cancer survival.

Claps F, van de Kamp MW, Mayr R, Bostrom PJ, Boormans JL, Eckstein M, Mertens LS, Boevé ER, Neuzillet Y, Burger M, Pouessel D, Trombetta C, Wullich B, van der Kwast TH, Hartmann A, Allory Y, Lotan Y, Shariat SF, Zuiverloon TCM, Mir MC, van Rhijn BWG. Claps F, et al. Among authors: van rhijn bwg. World J Urol. 2021 Dec;39(12):4363-4371. doi: 10.1007/s00345-021-03776-5. Epub 2021 Jul 1. World J Urol. 2021. PMID: 34196758 Free article.

116

Risk factors for residual disease at re-TUR in a large cohort of T1G3 patients.

Pisano F, Gontero P, Sylvester R, Joniau S, Serretta V, Larré S, Di Stasi S, van Rhijn B, Witjes A, Grotenhuis A, Colombo R, Briganti A, Babjuk M, Soukup V, Malmstrom PU, Irani J, Malats N, Baniel J, Mano R, Cai T, Cha E, Ardelt P, Varkarakis J, Bartoletti R, Dalbagni G, Shariat SF, Xylinas E, Karnes RJ, Palou J. Pisano F, et al. Among authors: van rhijn b. Actas Urol Esp (Engl Ed). 2021 Jul-Aug;45(6):473-478. doi: 10.1016/j.acuroe.2020.08.014. Epub 2021 Jun 17. Actas Urol Esp (Engl Ed). 2021. PMID: 34147426 English, Spanish.

117

Prognostic value of preoperative albumin-to-fibrinogen ratio (AFR) in patients with bladder cancer treated with radical cystectomy.

Claps F, Rai S, Mir MC, van Rhijn BWG, Mazzon G, Davis LE, Valadon CL, Silvestri T, Rizzo M, Ankem M, Liguori G, Celia A, Trombetta C, Pavan N. Claps F, et al. Among authors: van rhijn bwg. Urol Oncol. 2021 Dec;39(12):835.e9-835.e17. doi: 10.1016/j.urolonc.2021.04.026. Epub 2021 May 26. Urol Oncol. 2021. PMID: 34049782

118

Reply to Rodolfo Montironi, Marina Scarpelli, Alessia Cimadamore, and Gregor Mikuz's Letter to the Editor re: Theo van der Kwast, Fredrik Liedberg, Peter C. Black, et al. International Society of Urological Pathology Expert Opinion on Grading of Urothelial Carcinoma. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2021.03.017. Focus on Our Personal Recollections and Observations.

van der Kwast T, Van Rhijn B, Kamat A, Cheng L. van der Kwast T, et al. Among authors: van rhijn b. Eur Urol Focus. 2022 May;8(3):885-886. doi: 10.1016/j.euf.2021.04.025. Epub 2021 May 12. Eur Urol Focus. 2022. PMID: 33992577 No abstract available.

119

The Diagnostic Value of FDG-PET/CT for Urachal Cancer.

Stokkel LE, Stokkel MPM, Donswijk ML, Lahaye MJ, Bekers EM, van Rhijn BWG, Mertens LS. Stokkel LE, et al. Among authors: van rhijn bwg. Clin Genitourin Cancer. 2021 Oct;19(5):373-380. doi: 10.1016/j.clgc.2021.03.002. Epub 2021 Mar 17. Clin Genitourin Cancer. 2021. PMID: 33858788

120

International Society of Urological Pathology Expert Opinion on Grading of Urothelial Carcinoma.

van der Kwast T, Liedberg F, Black PC, Kamat A, van Rhijn BWG, Algaba F, Berman DM, Hartmann A, Lopez-Beltran A, Samaratunga H, Varma M, Cheng L. van der Kwast T, et al. Among authors: van rhijn bwg. Eur Urol Focus. 2022 Mar;8(2):438-446. doi: 10.1016/j.euf.2021.03.017. Epub 2021 Mar 24. Eur Urol Focus. 2022. PMID: 33771477 Review.

121

Association of patients' sex with treatment outcomes after intravesical bacillus Calmette-Guérin immunotherapy for T1G3/HG bladder cancer.

D'Andrea D, Soria F, Grotenhuis AJ, Cha EK, Malats N, Di Stasi S, Joniau S, Cai T, van Rhijn BWG, Irani J, Karnes J, Varkarakis J, Baniel J, Palou J, Babjuk M, Spahn M, Ardelt P, Colombo R, Serretta V, Dalbagni G, Gontero P, Bartoletti R, Larré S, Malmstrom PU, Sylvester R, Shariat SF. D'Andrea D, et al. Among authors: van rhijn bwg. World J Urol. 2021 Sep;39(9):3337-3344. doi: 10.1007/s00345-021-03653-1. Epub 2021 Mar 13. World J Urol. 2021. PMID: 33713162 Free PMC article.

122

Staging ¹⁸F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Changes Treatment Recommendation in Invasive Bladder Cancer.

Voskuilen CS, van Gennep EJ, Einerhand SMH, Vegt E, Donswijk ML, Bruining A, van der Poel HG, Horenblas S, Hendricksen K, van Rhijn BWG, Mertens LS. Voskuilen CS, et al. Among authors: van rhijn bwg. Eur Urol Oncol. 2022 Jun;5(3):366-369. doi: 10.1016/j.euo.2021.01.005. Epub 2021 Feb 11. Eur Urol Oncol. 2022. PMID: 33583752

123

Prognostic Value of the WHO1973 and WHO2004/2016 Classification Systems for Grade in Primary Ta/T1 Non-muscle-invasive Bladder Cancer: A Multicenter European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel Study.

van Rhijn BWG, Hentschel AE, Bründl J, Compérat EM, Hernández V, Čapoun O, Bruins HM, Cohen D, Rouprêt M, Shariat SF, Mostafid AH, Zigeuner R, Dominguez-Escrig JL, Burger M, Soukup V, Gontero P, Palou J, van der Kwast TH, Babjuk M, Sylvester RJ; Multi-center EAU Non-Muscle-Invasive Bladder Cancer Guidelines Panel Study Consortium on the WHO1973 WHO 2004 2016 Classification Systems for Grade. van Rhijn BWG, et al. Eur Urol Oncol. 2021 Apr;4(2):182-191. doi: 10.1016/j.euo.2020.12.002. Epub 2021 Jan 8. Eur Urol Oncol. 2021. PMID: 33423944

124

European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel.

Sylvester RJ, Rodríguez O, Hernández V, Turturica D, Bauerová L, Bruins HM, Bründl J, van der Kwast TH, Brisuda A, Rubio-Briones J, Seles M, Hentschel AE, Kusuma VRM, Huebner N, Cotte J, Mertens LS, Volanis D, Cussenot O, Subiela Henríquez JD, de la Peña E, Pisano F, Pešl M, van der Heijden AG, Herdegen S, Zlotta AR, Hacek J, Calatrava A, Mannweiler S, Bosschieter J, Ashabere D, Haitel A, Côté JF, El Sheikh S, Lunelli L, Algaba F, Alemany I, Soria F, Runneboom W, Breyer J, Nieuwenhuijzen JA, Llorente C, Molinaro L, Hulsbergen-van de Kaa CA, Evert M, Kiemeney LALM, N'Dow J, Plass K, Čapoun O, Soukup V, Dominguez-Escrig JL, Cohen D, Palou J, Gontero P, Burger M, Zigeuner R, Mostafid AH, Shariat SF, Rouprêt M, Compérat EM, Babjuk M, van Rhijn BWG. Sylvester RJ, et al. Among authors: van rhijn bwg. Eur Urol. 2021 Apr;79(4):480-488. doi: 10.1016/j.eururo.2020.12.033. Epub 2021 Jan 6. Eur Urol. 2021. PMID: 33419683

125

Hospital volume is associated with postoperative mortality after radical cystectomy for treatment of bladder cancer.

Richters A, Ripping TM, Kiemeney LA, Leliveld AM, van Rhijn BWG, Oddens JR, van Moorselaar RJA, Goossens-Laan CA, Meijer RP, Boormans JL; BlaZIB Study Group; Witjes JA, Aben KKH. Richters A, et al. Among authors: van rhijn bwg. BJU Int. 2021 Oct;128(4):511-518. doi: 10.1111/bju.15334. Epub 2021 Feb 15. BJU Int. 2021. PMID: 33404154 Free PMC article.

126

Sexual Satisfaction in Men Suffering From Erectile Dysfunction After Robot-Assisted Radical Prostatectomy for Prostate Cancer: An Observational Study.

Albers LF, Tillier CN, van Muilekom E, van Werkhoven E, Elzevier HW, van Rhijn BWG, van der Poel HG, Hendricksen K. Albers LF, et al. Among authors: van rhijn bwg. J Sex Med. 2021 Feb;18(2):339-346. doi: 10.1016/j.jsxm.2020.11.011. Epub 2020 Dec 24. J Sex Med. 2021. PMID: 33358558 Free article.

127

Neoadjuvant chemotherapy plus radical cystectomy versus radical cystectomy alone in clinical T2 bladder cancer without hydronephrosis.

Soria F, Black PC, Fairey AS, Cookson MS, Yu EY, Kassouf W, Dall'Era MA, Sridhar SS, McGrath JS, Wright JL, Thorpe AC, Morgan TM, Daneshmand S, Holzbeierlein JM, Bivalacqua TJ, North S, Barocas DA, Lotan Y, Grivas P, Stephenson AJ, Shah JB, van Rhijn BW, Spiess PE, Shariat SF, Gontero P. Soria F, et al. Among authors: van rhijn bw. BJU Int. 2021 Jul;128(1):79-87. doi: 10.1111/bju.15289. Epub 2020 Nov 21. BJU Int. 2021. PMID: 33152179 Free article.

128

Preoperative ipilimumab plus nivolumab in locoregionally advanced urothelial cancer: the NABUCCO trial.

van Dijk N, Gil-Jimenez A, Silina K, Hendricksen K, Smit LA, de Feijter JM, van Montfoort ML, van Rooijen C, Peters D, Broeks A, van der Poel HG, Bruining A, Lubeck Y, Sikorska K, Boellaard TN, Kvistborg P, Vis DJ, Hooijberg E, Schumacher TN, van den Broek M, Wessels LFA, Blank CU, van Rhijn BW, van der Heijden MS. van Dijk N, et al. Among authors: van rhijn bw. Nat Med. 2020 Dec;26(12):1839-1844. doi: 10.1038/s41591-020-1085-z. Epub 2020 Oct 12. Nat Med. 2020. PMID: 33046870 Clinical Trial.

129

The Performance of Tumor Size as Risk Stratification Parameter in Upper Tract Urothelial Carcinoma (UTUC).

Foerster B, Abufaraj M, Mari A, Seisen T, Bandini M, Schweitzer D, Czech AK, Moschini M, D'Andrea D, Bianchi M, Hendricksen K, Rouprêt M, Briganti A, van Rhijn BWG, Chłosta P, Colin P, John H, Shariat SF. Foerster B, et al. Among authors: van rhijn bwg. Clin Genitourin Cancer. 2021 Jun;19(3):272.e1-272.e7. doi: 10.1016/j.clgc.2020.09.002. Epub 2020 Sep 18. Clin Genitourin Cancer. 2021. PMID: 33046411

130

The comprehensive complication index is associated with a significant increase in complication severity between 30 and 90 days after radical cystectomy for bladder cancer.

Haas M, Huber T, Pickl C, van Rhijn BWG, Gužvić M, Gierth M, Breyer J, Burger M, Mayr R. Haas M, et al. Among authors: van rhijn bwg. Eur J Surg Oncol. 2021 May;47(5):1163-1171. doi: 10.1016/j.ejso.2020.09.040. Epub 2020 Oct 5. Eur J Surg Oncol. 2021. PMID: 33046281

131

The clonal relation of primary upper urinary tract urothelial carcinoma and paired urothelial carcinoma of the bladder.

van Doeveren T, Nakauma-Gonzalez JA, Mason AS, van Leenders GJLH, Zuiverloon TCM, Zwarthoff EC, Meijssen IC, van der Made AC, van der Heijden AG, Hendricksen K, van Rhijn BWG, Voskuilen CS, van Riet J, Dinjens WNM, Dubbink HJ, van de Werken HJG, Boormans JL. van Doeveren T, et al. Among authors: van rhijn bwg. Int J Cancer. 2021 Feb 15;148(4):981-987. doi: 10.1002/ijc.33327. Epub 2020 Oct 13. Int J Cancer. 2021. PMID: 33006377 Free PMC article.

132

Comparative effectiveness of neoadjuvant chemotherapy in bladder and upper urinary tract urothelial carcinoma.

D'Andrea D, Matin S, Black PC, Petros FG, Zargar H, Dinney CP, Cookson MS, Kassouf W, Dall'Era MA, McGrath JS, Wright JL, Thorpe AC, Morgan TM, Holzbeierlein JM, Bivalacqua TJ, Sridhar SS, North S, Barocas DA, Lotan Y, Stephenson AJ, van Rhijn BW, Spiess PE, Daneshmand S, Shariat SF. D'Andrea D, et al. Among authors: van rhijn bw. BJU Int. 2021 May;127(5):528-537. doi: 10.1111/bju.15253. Epub 2020 Oct 14. BJU Int. 2021. PMID: 32981193 Free PMC article.

133

Hospital-specific probability of cystectomy affects survival from muscle-invasive bladder cancer.

Ripping TM, Witjes JA, Meijer RP, van Rhijn BWG, Oddens JR, Goossens-Laan CA, Mulder SF, van Moorselaar RJA, Kiemeney LA, Aben KKH. Ripping TM, et al. Among authors: van rhijn bwg. Urol Oncol. 2020 Dec;38(12):935.e9-935.e16. doi: 10.1016/j.urolonc.2020.08.014. Epub 2020 Sep 8. Urol Oncol. 2020. PMID: 32917503

134

The association of cigarette smoking and pathological response to neoadjuvant platinum-based chemotherapy in patients undergoing treatment for urinary bladder cancer - A prospective European multicenter observational study of the EAU Young Academic Urologists (YAU) urothelial carcinoma working group.

Gild P, Vetterlein MW, Seiler R, Necchi A, Hendricksen K, Mertens LS, Roghmann F, Landenberg NV, Gontero P, Cumberbatch M, Dobruch J, Seisen T, Grande P, D'Andrea D, Anract J, Comploj E, Pycha A, Saba K, Poyet C, van Rhijn BW, Noon AP, Roupret M, Shariat SF, Fisch M, Xylinas E, Rink M. Gild P, et al. Among authors: van rhijn bw. Surg Oncol. 2020 Sep;34:312-317. doi: 10.1016/j.suronc.2020.06.006. Epub 2020 Jun 30. Surg Oncol. 2020. PMID: 32891350

135

Reassessment of p53 immunohistochemistry thresholds in invasive high grade bladder cancer shows a better correlation with TP53 and FGFR3 mutations.

Hodgson A, van Rhijn BWG, Kim SS, Ding C, Saleeb R, Vesprini D, Liu SK, Yousef GM, van der Kwast TH, Xu B, Downes MR. Hodgson A, et al. Among authors: van rhijn bwg. Pathol Res Pract. 2020 Nov;216(11):153186. doi: 10.1016/j.prp.2020.153186. Epub 2020 Aug 23. Pathol Res Pract. 2020. PMID: 32861170

136

Nomogram Predicting Bladder Cancer-specific Mortality After Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-invasive Bladder Cancer: Results of an International Consortium.

Mir MC, Marchioni M, Zargar H, Zargar-Shoshtari K, Fairey AS, Mertens LS, Dinney CP, Krabbe LM, Cookson MS, Jacobsen NE, Griffin J, Montgomery JS, Vasdev N, Yu EY, Xylinas E, McGrath JS, Kassouf W, Dall'Era MA, Sridhar SS, Aning J, Shariat SF, Wright JL, Thorpe AC, Morgan TM, Holzbeierlein JM, Bivalacqua TJ, North S, Barocas DA, Lotan Y, Grivas P, Stephenson AJ, Shah JB, van Rhijn BW, Spiess PE, Daneshmand D, Black PC. Mir MC, et al. Among authors: van rhijn bw. Eur Urol Focus. 2021 Nov;7(6):1347-1354. doi: 10.1016/j.euf.2020.07.002. Epub 2020 Aug 6. Eur Urol Focus. 2021. PMID: 32771446

137

Radiation with concurrent radiosensitizing capecitabine tablets and single-dose mitomycin-C for muscle-invasive bladder cancer: A convenient alternative to 5-fluorouracil.

Voskuilen CS, van de Kamp MW, Schuring N, Mertens LS, Noordzij A, Pos F, van Rhijn BWG, van der Heijden MS, Schaake EE. Voskuilen CS, et al. Among authors: van rhijn bwg. Radiother Oncol. 2020 Sep;150:275-280. doi: 10.1016/j.radonc.2020.07.057. Epub 2020 Aug 6. Radiother Oncol. 2020. PMID: 32768507

138

18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in muscle-invasive bladder cancer.

Einerhand SMH, van Gennep EJ, Mertens LS, Hendricksen K, Donswijk ML, van der Poel HG, van Rhijn BWG. Einerhand SMH, et al. Among authors: van rhijn bwg. Curr Opin Urol. 2020 Sep;30(5):654-664. doi: 10.1097/MOU.0000000000000798. Curr Opin Urol. 2020. PMID: 32701719 Review.

139

FGFR3 Mutation Status and FGFR3 Expression in a Large Bladder Cancer Cohort Treated by Radical Cystectomy: Implications for Anti-FGFR3 Treatment?^†.

van Rhijn BWG, Mertens LS, Mayr R, Bostrom PJ, Real FX, Zwarthoff EC, Boormans JL, Abas C, van Leenders GJLH, Götz S, Hippe K, Bertz S, Neuzillet Y, Sanders J, Broeks A, van der Heijden MS, Jewett MAS, Marquez M, Stoehr R, Zlotta AR, Eckstein M, Soorojebally Y, Roshani H, Burger M, Otto W, Radvanyi F, Sirab N, Pouessel D, Wullich B, van der Kwast TH, Malats N, Hartmann A, Allory Y, Zuiverloon TCM. van Rhijn BWG, et al. Eur Urol. 2020 Nov;78(5):682-687. doi: 10.1016/j.eururo.2020.07.002. Epub 2020 Jul 15. Eur Urol. 2020. PMID: 32682615

140

Epigenetic profiling demarcates molecular subtypes of muscle-invasive bladder cancer.

van der Vos KE, Vis DJ, Nevedomskaya E, Kim Y, Choi W, McConkey D, Wessels LFA, van Rhijn BWG, Zwart W, van der Heijden MS. van der Vos KE, et al. Among authors: van rhijn bwg. Sci Rep. 2020 Jul 2;10(1):10952. doi: 10.1038/s41598-020-67850-5. Sci Rep. 2020. PMID: 32616859 Free PMC article.

141

European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update.

Rouprêt M, Babjuk M, Burger M, Capoun O, Cohen D, Compérat EM, Cowan NC, Dominguez-Escrig JL, Gontero P, Hugh Mostafid A, Palou J, Peyronnet B, Seisen T, Soukup V, Sylvester RJ, Rhijn BWGV, Zigeuner R, Shariat SF. Rouprêt M, et al. Among authors: rhijn bwgv. Eur Urol. 2021 Jan;79(1):62-79. doi: 10.1016/j.eururo.2020.05.042. Epub 2020 Jun 24. Eur Urol. 2021. PMID: 32593530

142

A testosterone-producing Leydig cell tumor metastasis during hormonal treatment of prostate cancer.

Stokkel L, van der Poel HG, Langbein SI, Kerst JM, de Jong J, van Rhijn BWG. Stokkel L, et al. Among authors: van rhijn bwg. Urol Ann. 2020 Apr-Jun;12(2):180-183. doi: 10.4103/UA.UA_38_19. Epub 2020 Apr 14. Urol Ann. 2020. PMID: 32565659 Free PMC article.

143

Impact of Sex on Response to Neoadjuvant Chemotherapy in Patients with Upper-tract Urothelial Cancer.

D'Andrea D, Foerster B, Matin SF, Ku JH, Muilwijk T, Monteiro LL, Liao R, Petros FG, Spiess PE, Bivalacqua TJ, Hendricksen K, van Rhijn BWG, Shabsigh A, Briganti A, Joniau S, Kassouf W, Pierorazio PM, Margulis V, Necchi A, Shariat SF; UTUC collaboration. D'Andrea D, et al. Among authors: van rhijn bwg. Eur Urol Open Sci. 2020 Jun 14;19:16-19. doi: 10.1016/j.euros.2020.04.001. eCollection 2020 Jul. Eur Urol Open Sci. 2020. PMID: 34337449 Free PMC article. No abstract available.

144

Insight into bladder cancer care: study protocol of a large nationwide prospective cohort study (BlaZIB).

Ripping TM, Kiemeney LA, van Hoogstraten LMC, Witjes JA, Aben KKH; BlaZIB study group. Ripping TM, et al. BMC Cancer. 2020 May 20;20(1):455. doi: 10.1186/s12885-020-06954-7. BMC Cancer. 2020. PMID: 32434491 Free PMC article.

145

ASO Author Reflections: How to Detect Peritoneal Metastases of Urachal Carcinoma? The Value of Diagnostic Laparoscopy and Abdominal Cytology in Staging This Rare Malignancy.

Stokkel LE, Mertens LS, van Rhijn BWG. Stokkel LE, et al. Among authors: van rhijn bwg. Ann Surg Oncol. 2020 Jul;27(7):2476-2477. doi: 10.1245/s10434-020-08503-9. Epub 2020 Apr 22. Ann Surg Oncol. 2020. PMID: 32323088 No abstract available.

146

Authors' response to Letter to the Editor "Don't forget Arnhem".

Voskuilen CS, Bosschieter J, Nieuwenhuijzen JA, van Rhijn BWG. Voskuilen CS, et al. Among authors: van rhijn bwg. Radiother Oncol. 2020 Jun;147:237. doi: 10.1016/j.radonc.2020.03.005. Epub 2020 Mar 26. Radiother Oncol. 2020. PMID: 32223940 No abstract available.

147

Distribution of Molecular Subtypes in Muscle-invasive Bladder Cancer Is Driven by Sex-specific Differences.

de Jong JJ, Boormans JL, van Rhijn BWG, Seiler R, Boorjian SA, Konety B, Bivalacqua TJ, Wheeler T, Svatek RS, Douglas J, Wright J, Dall'Era M, Crabb SJ, Efstathiou JA, van der Heijden MS, Mouw KW, Miyamoto DT, Lotan Y, Black PC, Gibb EA, Porten SP. de Jong JJ, et al. Among authors: van rhijn bwg. Eur Urol Oncol. 2020 Aug;3(4):420-423. doi: 10.1016/j.euo.2020.02.010. Epub 2020 Mar 20. Eur Urol Oncol. 2020. PMID: 32205136

148

Transurethral Resection of Bladder Tumour: The Neglected Procedure in the Technology Race in Bladder Cancer.

Mostafid H, Babjuk M, Bochner B, Lerner SP, Witjes F, Palou J, Roupret M, Shariat S, Gontero P, van Rhijn B, Zigeuner R, Sylvester R, Comperat E, Burger M, Malavaud B, Soloway M, Williams S, Black P, Daneshmand S, Steinberg G, Brausi M, Catto J, Kamat AM. Mostafid H, et al. Among authors: van rhijn b. Eur Urol. 2020 Jun;77(6):669-670. doi: 10.1016/j.eururo.2020.03.005. Epub 2020 Mar 17. Eur Urol. 2020. PMID: 32192815

149

Impact of sex on response to neoadjuvant chemotherapy in patients with bladder cancer.

D'Andrea D, Black PC, Zargar H, Zargar-Shoshtari K, Zehetmayer S, Fairey AS, Mertens LS, Dinney CP, Mir MC, Krabbe LM, Cookson MS, Jacobsen NE, Montgomery JS, Vasdev N, Yu EY, Xylinas E, Campain NJ, Kassouf W, Dall'Era MA, Seah JA, Ercole CE, Horenblas S, Sridhar SS, McGrath JS, Aning J, Wright JL, Thorpe AC, Morgan TM, Holzbeierlein JM, Bivalacqua TJ, North S, Barocas DA, Lotan Y, Grivas P, Stephenson AJ, Shah JB, van Rhijn BW, Daneshmand S, Spiess PE, Shariat SF. D'Andrea D, et al. Among authors: van rhijn bw. Urol Oncol. 2020 Jul;38(7):639.e1-639.e9. doi: 10.1016/j.urolonc.2020.01.010. Epub 2020 Feb 11. Urol Oncol. 2020. PMID: 32057595

150

Diagnostic Laparoscopy and Abdominal Cytology Reliably Detect Peritoneal Metastases in Patients with Urachal Adenocarcinoma.

Stokkel LE, Mehta AM, Behrendt MA, de Jong J, Bekers EM, Hendricksen K, Aalbers AGJ, Kok NFM, Meinhardt W, Mertens LS, van Rhijn BWG. Stokkel LE, et al. Among authors: van rhijn bwg. Ann Surg Oncol. 2020 Jul;27(7):2468-2475. doi: 10.1245/s10434-020-08206-1. Epub 2020 Feb 12. Ann Surg Oncol. 2020. PMID: 32052302

151

Non-visible haematuria for the Detection of Bladder, Upper Tract, and Kidney Cancer: An Updated Systematic Review and Meta-analysis.

Jubber I, Shariat SF, Conroy S, Tan WS, Gordon PC, Lotan Y, Messing EM, Stenzl A, Rhijn BV, Kelly JD, Catto JWF, Cumberbatch MG. Jubber I, et al. Among authors: rhijn bv. Eur Urol. 2020 May;77(5):583-598. doi: 10.1016/j.eururo.2019.10.010. Epub 2019 Nov 30. Eur Urol. 2020. PMID: 31791622

152

Prediction of early (30-day) and late (30-90-day) mortality after radical cystectomy in a comprehensive cancer centre over two decades.

Korbee ML, Voskuilen CS, Hendricksen K, Mayr R, Wit EM, van Leeuwen PJ, Horenblas S, Meinhardt W, Burger M, Bex A, van der Poel HG, van Rhijn BWG. Korbee ML, et al. Among authors: van rhijn bwg. World J Urol. 2020 Sep;38(9):2197-2205. doi: 10.1007/s00345-019-03011-2. Epub 2019 Nov 14. World J Urol. 2020. PMID: 31728672

153

Papillary urothelial neoplasm of low malignant potential (PUN-LMP): Still a meaningful histo-pathological grade category for Ta, noninvasive bladder tumors in 2019?

Hentschel AE, van Rhijn BWG, Bründl J, Compérat EM, Plass K, Rodríguez O, Henríquez JDS, Hernández V, de la Peña E, Alemany I, Turturica D, Pisano F, Soria F, Čapoun O, Bauerová L, Pešl M, Bruins HM, Runneboom W, Herdegen S, Breyer J, Brisuda A, Scavarda-Lamberti A, Calatrava A, Rubio-Briones J, Seles M, Mannweiler S, Bosschieter J, Kusuma VRM, Ashabere D, Huebner N, Cotte J, Mertens LS, Cohen D, Lunelli L, Cussenot O, Sheikh SE, Volanis D, Coté JF, Rouprêt M, Haitel A, Shariat SF, Mostafid AH, Nieuwenhuijzen JA, Zigeuner R, Dominguez-Escrig JL, Hacek J, Zlotta AR, Burger M, Evert M, Hulsbergen-van de Kaa CA, van der Heijden AG, Kiemeney LALM, Soukup V, Molinaro L, Gontero P, Llorente C, Algaba F, Palou J, N'Dow J, Babjuk M, van der Kwast TH, Sylvester RJ. Hentschel AE, et al. Among authors: van rhijn bwg. Urol Oncol. 2020 May;38(5):440-448. doi: 10.1016/j.urolonc.2019.10.002. Epub 2019 Nov 5. Urol Oncol. 2020. PMID: 31704141

154

Complication rate after cystectomy following pelvic radiotherapy: an international, multicenter, retrospective series of 682 cases.

Gontero P, Pisano F, Palou J, Joniau S, Albersen M, Colombo R, Briganti A, Pellucchi F, Faba OR, van Rhijn BW, van de Putte EF, Babjuk M, Fritsche HM, Mayr R, Albers P, Niegisch G, Anract J, Masson-Lecomte A, De la Taille A, Roupret M, Peyronnet B, Cai T, Witjes AJ, Bruins M, Baniel J, Mano R, Lapini A, Sessa F, Irani J, Brausi M, Stenzl A, Karnes JR, Scherr D, O'Malley P, Taylor B, Shariat SF, Black P, Abdi H, Matveev VB, Samuseva O, Parekh D, Gonzalgo M, Vetterlein MW, Aziz A, Fisch M, Catto J, Pang KH, Xylinas E, Rink M; Young Academic Urologists Urothelial Carcinoma Group of the European Association of Urology. Gontero P, et al. Among authors: van rhijn bw. World J Urol. 2020 Aug;38(8):1959-1968. doi: 10.1007/s00345-019-02982-6. Epub 2019 Nov 6. World J Urol. 2020. PMID: 31691084

155

The prognostic value of the neutrophil-to-lymphocyte ratio in patients with muscle-invasive bladder cancer treated with neoadjuvant chemotherapy and radical cystectomy.

Black AJ, Zargar H, Zargar-Shoshtari K, Fairey AS, Mertens LS, Dinney CP, Mir MC, Krabbe LM, Cookson MS, Jacobsen NE, Griffin J, Montgomery JS, Vasdev N, Yu EY, Xylinas E, Campain NJ, Kassouf W, Dall'Era MA, Seah JA, Ercole CE, Horenblas S, McGrath JS, Aning J, Shariat SF, Wright JL, Thorpe AC, Morgan TM, Holzbeierlein JM, Bivalacqua TJ, North S, Barocas DA, Lotan Y, Grivas P, Stephenson AJ, Shah JB, van Rhijn BW, Spiess PE, Daneshmand S, Sridhar SS, Black PC. Black AJ, et al. Among authors: van rhijn bw. Urol Oncol. 2020 Jan;38(1):3.e17-3.e27. doi: 10.1016/j.urolonc.2019.09.023. Epub 2019 Oct 31. Urol Oncol. 2020. PMID: 31676278

156

Long-term survival and complications following bladder-preserving brachytherapy in patients with cT1-T2 bladder cancer.

Voskuilen CS, Bosschieter J, van Werkhoven E, Hendricksen K, Vis AN, Witteveen T, Pieters BR, Burger M, Bex A, van der Poel HG, Moonen LM, Horenblas S, Nieuwenhuijzen JA, van Rhijn BWG. Voskuilen CS, et al. Among authors: van rhijn bwg. Radiother Oncol. 2019 Dec;141:130-136. doi: 10.1016/j.radonc.2019.09.026. Epub 2019 Oct 17. Radiother Oncol. 2019. PMID: 31630869

157

Long non-coding RNAs identify a subset of luminal muscle-invasive bladder cancer patients with favorable prognosis.

de Jong JJ, Liu Y, Robertson AG, Seiler R, Groeneveld CS, van der Heijden MS, Wright JL, Douglas J, Dall'Era M, Crabb SJ, van Rhijn BWG, van Kessel KEM, Davicioni E, Castro MAA, Lotan Y, Zwarthoff EC, Black PC, Boormans JL, Gibb EA. de Jong JJ, et al. Among authors: van rhijn bwg. Genome Med. 2019 Oct 17;11(1):60. doi: 10.1186/s13073-019-0669-z. Genome Med. 2019. PMID: 31619281 Free PMC article.

158

Diagnostic Value of ¹⁸F-fluorodeoxyglucose Positron Emission Tomography with Computed Tomography for Lymph Node Staging in Patients with Upper Tract Urothelial Carcinoma.

Voskuilen CS, Schweitzer D, Jensen JB, Nielsen AM, Joniau S, Muilwijk T, Necchi A, Azizi M, Spiess PE, Briganti A, Bandini M, Goffin K, Bouchelouche K, van Werkhoven E, Shariat SF, Xylinas E, Azawi NH, Ku JH, Foerster B, van Rhijn BWG, Vegt E, Hendricksen K. Voskuilen CS, et al. Among authors: van rhijn bwg. Eur Urol Oncol. 2020 Feb;3(1):73-79. doi: 10.1016/j.euo.2019.09.004. Epub 2019 Oct 5. Eur Urol Oncol. 2020. PMID: 31591037

159

Multicenter Validation of Histopathologic Tumor Regression Grade After Neoadjuvant Chemotherapy in Muscle-invasive Bladder Carcinoma.

Voskuilen CS, Oo HZ, Genitsch V, Smit LA, Vidal A, Meneses M, Necchi A, Colecchia M, Xylinas E, Fontugne J, Sibony M, Rouprêt M, Lenfant L, Côté JF, Buser L, Saba K, Furrer MA, van der Heijden MS, Daugaard M, Black PC, van Rhijn BWG, Hendricksen K, Poyet C, Seiler R. Voskuilen CS, et al. Among authors: van rhijn bwg. Am J Surg Pathol. 2019 Dec;43(12):1600-1610. doi: 10.1097/PAS.0000000000001371. Am J Surg Pathol. 2019. PMID: 31524642 Free article.

160

European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update.

Babjuk M, Burger M, Compérat EM, Gontero P, Mostafid AH, Palou J, van Rhijn BWG, Rouprêt M, Shariat SF, Sylvester R, Zigeuner R, Capoun O, Cohen D, Escrig JLD, Hernández V, Peyronnet B, Seisen T, Soukup V. Babjuk M, et al. Among authors: van rhijn bwg. Eur Urol. 2019 Nov;76(5):639-657. doi: 10.1016/j.eururo.2019.08.016. Epub 2019 Aug 20. Eur Urol. 2019. PMID: 31443960 Review.

161

Re: Multicenter Prospective Phase II Trial of Neoadjuvant Dose-dense Gemcitabine Plus Cisplatin in Patients with Muscle-invasive Bladder Cancer.

Voskuilen CS, van der Heijden MS, van Rhijn BWG. Voskuilen CS, et al. Among authors: van rhijn bwg. Eur Urol. 2019 Dec;76(6):870-871. doi: 10.1016/j.eururo.2019.07.019. Epub 2019 Jul 25. Eur Urol. 2019. PMID: 31351667 No abstract available.

162

Long-term survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for patients with peritoneal metastases of urachal cancer.

Mertens LS, Behrendt MA, Mehta AM, Stokkel L, de Jong J, Boot H, Horenblas S, van der Heijden MS, Moonen LM, Aalbers AGJ, Meinhardt W, van Rhijn BWG. Mertens LS, et al. Among authors: van rhijn bwg. Eur J Surg Oncol. 2019 Sep;45(9):1740-1744. doi: 10.1016/j.ejso.2019.03.034. Epub 2019 Apr 1. Eur J Surg Oncol. 2019. PMID: 31003721

163

Molecular Characterization of Neuroendocrine-like Bladder Cancer.

Batista da Costa J, Gibb EA, Bivalacqua TJ, Liu Y, Oo HZ, Miyamoto DT, Alshalalfa M, Davicioni E, Wright J, Dall'Era MA, Douglas J, Boormans JL, Van der Heijden MS, Wu CL, van Rhijn BWG, Gupta S, Grivas P, Mouw KW, Murugan P, Fazli L, Ra S, Konety BR, Seiler R, Daneshmand S, Mian OY, Efstathiou JA, Lotan Y, Black PC. Batista da Costa J, et al. Among authors: van rhijn bwg. Clin Cancer Res. 2019 Jul 1;25(13):3908-3920. doi: 10.1158/1078-0432.CCR-18-3558. Epub 2019 Apr 5. Clin Cancer Res. 2019. PMID: 30952638

164

Urothelial Carcinoma in Bladder Diverticula: A Multicenter Analysis of Characteristics and Clinical Outcomes.

Voskuilen CS, Seiler R, Rink M, Poyet C, Noon AP, Roghmann F, Necchi A, Aziz A, Lavollé A, Young MJ, Marks P, Saba K, van Rhijn BWG, Fransen van de Putte EE, Ablat J, Black PC, Sosnowski R, Dobruch J, Kumar P, Jallad S, Catto JWF, Xylinas E, Hendricksen K; Young Academic Urologists’ Working Group on Urothelial Carcinoma of the European Association of Urology. Voskuilen CS, et al. Among authors: van rhijn bwg. Eur Urol Focus. 2020 Nov 15;6(6):1226-1232. doi: 10.1016/j.euf.2018.12.002. Epub 2018 Dec 14. Eur Urol Focus. 2020. PMID: 30559065

165

Outcome of sentinel lymph node biopsy in patients with clinically non-metastatic renal cell carcinoma.

Kuusk T, De Bruijn R, Brouwer OR, De Jong J, Donswijk M, Hendricksen K, Horenblas S, Jóźwiak K, Prevoo W, Valdés Olmos RA, Van Der Poel HG, Van Rhijn BW, Wit EM, Bex A. Kuusk T, et al. Among authors: van rhijn bw. Scand J Urol. 2018 Oct-Dec;52(5-6):411-418. doi: 10.1080/21681805.2018.1531057. Epub 2018 Dec 11. Scand J Urol. 2018. PMID: 30526184

166

An analysis of SPECT/CT non-visualization of sentinel lymph nodes in renal tumors.

Kuusk T, Donswijk ML, Valdés Olmos RA, De Bruijn RE, Brouwer OR, Hendricksen K, Horenblas S, Jóźwiak K, Prevoo W, Van Der Poel HG, Van Rhijn BWG, Wit EM, Bex A. Kuusk T, et al. Among authors: van rhijn bwg. EJNMMI Res. 2018 Dec 3;8(1):105. doi: 10.1186/s13550-018-0460-y. EJNMMI Res. 2018. PMID: 30511175 Free PMC article.

167

Risk Stratification Tools and Prognostic Models in Non-muscle-invasive Bladder Cancer: A Critical Assessment from the European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel.

Soukup V, Čapoun O, Cohen D, Hernández V, Burger M, Compérat E, Gontero P, Lam T, Mostafid AH, Palou J, van Rhijn BWG, Rouprêt M, Shariat SF, Sylvester R, Yuan Y, Zigeuner R, Babjuk M. Soukup V, et al. Among authors: van rhijn bwg. Eur Urol Focus. 2020 May 15;6(3):479-489. doi: 10.1016/j.euf.2018.11.005. Epub 2018 Nov 22. Eur Urol Focus. 2020. PMID: 30470647 Review.

168

Concurrent Radiotherapy and Panitumumab after Lymph Node Dissection and Induction Chemotherapy for Invasive Bladder Cancer.

Fransen van de Putte EE, Pos F, Doodeman B, van Rhijn BWG, van der Laan E, Nederlof P, van der Heijden MS, Bloos-van der Hulst J, Sanders J, Broeks A, Kerst JM, van der Noort V, Horenblas S, Bergman AM. Fransen van de Putte EE, et al. Among authors: van rhijn bwg. J Urol. 2019 Mar;201(3):478-485. doi: 10.1016/j.juro.2018.10.007. J Urol. 2019. PMID: 30321552

169

Divergent Biological Response to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer.

Seiler R, Gibb EA, Wang NQ, Oo HZ, Lam HM, van Kessel KE, Voskuilen CS, Winters B, Erho N, Takhar MM, Douglas J, Vakar-Lopez F, Crabb SJ, van Rhijn BWG, Fransen van de Putte EE, Zwarthoff EC, Thalmann GN, Davicioni E, Boormans JL, Dall'Era M, van der Heijden MS, Wright JL, Black PC. Seiler R, et al. Among authors: van rhijn bwg. Clin Cancer Res. 2019 Aug 15;25(16):5082-5093. doi: 10.1158/1078-0432.CCR-18-1106. Epub 2018 Sep 17. Clin Cancer Res. 2019. PMID: 30224344 Free article.

170

Predictors of oncological outcomes in T1G3 patients treated with BCG who undergo radical cystectomy.

Soria F, Pisano F, Gontero P, Palou J, Joniau S, Serretta V, Larré S, Di Stasi S, van Rhijn B, Witjes JA, Grotenhuis A, Colombo R, Briganti A, Babjuk M, Soukup V, Malmstrom PU, Irani J, Malats N, Baniel J, Mano R, Cai T, Cha E, Ardelt P, Varkarakis J, Bartoletti R, Dalbagni G, Shariat SF, Xylinas E, Karnes RJ, Sylvester R. Soria F, et al. Among authors: van rhijn b. World J Urol. 2018 Nov;36(11):1775-1781. doi: 10.1007/s00345-018-2450-0. Epub 2018 Aug 31. World J Urol. 2018. PMID: 30171454 Free PMC article.

171

Superior efficacy of neoadjuvant chemotherapy and radical cystectomy in cT3-4aN0M0 compared to cT2N0M0 bladder cancer.

Hermans TJN, Voskuilen CS, Deelen M, Mertens LS, Horenblas S, Meijer RP, Boormans JL, Aben KK, van der Heijden MS, Pos FJ, de Wit R, Beerepoot LV, Verhoeven RHA, van Rhijn BWG. Hermans TJN, et al. Among authors: van rhijn bwg. Int J Cancer. 2019 Mar 15;144(6):1453-1459. doi: 10.1002/ijc.31833. Epub 2018 Sep 24. Int J Cancer. 2019. PMID: 30155893

172

Indication for a Single Postoperative Instillation of Chemotherapy in Non-muscle-invasive Bladder Cancer: What Factors Should Be Considered?

Babjuk M, Burger M, Compérat EM, Gontero P, Mostafid HA, Palou J, van Rhijn BWG, Rouprêt M, Shariat SF, Sylvester R, Zigeuner R, Capoun O, Cohen D, Dominguez-Escrig JL, Hernández V, Peyronnet B, Seisen T, Soukup V; European Association of Urology Guidelines Panel on Non–muscle-invasive Bladder Cancer. Babjuk M, et al. Among authors: van rhijn bwg. Eur Urol Focus. 2018 Jul;4(4):525-528. doi: 10.1016/j.euf.2018.07.023. Epub 2018 Jul 27. Eur Urol Focus. 2018. PMID: 30061076

173

Treatment Strategy for Newly Diagnosed T1 High-grade Bladder Urothelial Carcinoma: New Insights and Updated Recommendations.

Klaassen Z, Kamat AM, Kassouf W, Gontero P, Villavicencio H, Bellmunt J, van Rhijn BWG, Hartmann A, Catto JWF, Kulkarni GS. Klaassen Z, et al. Among authors: van rhijn bwg. Eur Urol. 2018 Nov;74(5):597-608. doi: 10.1016/j.eururo.2018.06.024. Epub 2018 Jul 13. Eur Urol. 2018. PMID: 30017405

174

Prostate sparing cystectomy for bladder cancer: A two-center study.

Voskuilen CS, Fransen van de Putte EE, Pérez-Reggeti JI, van Werkhoven E, Mertens LS, van Rhijn BWG, Saad M, Bex A, Cathelineau X, van der Poel HG, Horenblas S, Sanchez-Salas R, Meijer RP. Voskuilen CS, et al. Among authors: van rhijn bwg. Eur J Surg Oncol. 2018 Sep;44(9):1446-1452. doi: 10.1016/j.ejso.2018.05.032. Epub 2018 Jun 8. Eur J Surg Oncol. 2018. PMID: 29929902

175

Reproducibility and Prognostic Performance of the 1973 and 2004 World Health Organization Classifications for Grade in Non-muscle-invasive Bladder Cancer: A Multicenter Study in 328 Bladder Tumors.

Bosschieter J, Hentschel A, Savci-Heijink CD, Patrick van der Voorn J, Rozendaal L, Vis AN, van Rhijn BWG, Lissenberg-Witte BI, Fransen van de Putte EE, van Moorselaar RJA, Nieuwenhuijzen JA. Bosschieter J, et al. Among authors: van rhijn bwg. Clin Genitourin Cancer. 2018 Oct;16(5):e985-e992. doi: 10.1016/j.clgc.2018.05.002. Epub 2018 May 11. Clin Genitourin Cancer. 2018. PMID: 29884516

176

Concomitant CIS on TURBT does not impact oncological outcomes in patients treated with neoadjuvant or induction chemotherapy followed by radical cystectomy.

Vasdev N, Zargar H, Noël JP, Veeratterapillay R, Fairey AS, Mertens LS, Dinney CP, Mir MC, Krabbe LM, Cookson MS, Jacobsen NE, Gandhi NM, Griffin J, Montgomery JS, Yu EY, Xylinas E, Campain NJ, Kassouf W, Dall'Era MA, Seah JA, Ercole CE, Horenblas S, Sridhar SS, McGrath JS, Aning J, Shariat SF, Wright JL, Morgan TM, Bivalacqua TJ, North S, Barocas DA, Lotan Y, Grivas P, Stephenson AJ, Shah JB, van Rhijn BW, Daneshmand S, Spiess PE, Holzbeierlein JM, Thorpe A, Black PC. Vasdev N, et al. Among authors: van rhijn bw. World J Urol. 2019 Jan;37(1):165-172. doi: 10.1007/s00345-018-2361-0. Epub 2018 Jun 7. World J Urol. 2019. PMID: 29882105

177

Metric substage according to micro and extensive lamina propria invasion improves prognostics in T1 bladder cancer.

Fransen van de Putte EE, Otto W, Hartmann A, Bertz S, Mayr R, Bründl J, Breyer J, Manach Q, Compérat EM, Boormans JL, Bosschieter J, Jewett MAS, Stoehr R, van Leenders GJLH, Nieuwenhuijzen JA, Zlotta AR, Hendricksen K, Rouprêt M, Burger M, van der Kwast TH, van Rhijn BWG. Fransen van de Putte EE, et al. Among authors: van rhijn bwg. Urol Oncol. 2018 Aug;36(8):361.e7-361.e13. doi: 10.1016/j.urolonc.2018.05.007. Epub 2018 Jun 5. Urol Oncol. 2018. PMID: 29880460

178

Recurrence, progression and cancer-specific mortality according to stage at re-TUR in T1G3 bladder cancer patients treated with BCG: not as bad as previously thought.

Palou J, Pisano F, Sylvester R, Joniau S, Serretta V, Larré S, Di Stasi S, van Rhijn B, Witjes AJ, Grotenhuis A, Colombo R, Briganti A, Babjuk M, Soukup V, Malmstrom PU, Irani J, Malats N, Baniel J, Mano R, Cai T, Cha EK, Ardelt P, Varkarakis J, Bartoletti R, Dalbagni G, Shariat SF, Xylinas E, Karnes RJ, Gontero P. Palou J, et al. Among authors: van rhijn b. World J Urol. 2018 Oct;36(10):1621-1627. doi: 10.1007/s00345-018-2299-2. Epub 2018 May 2. World J Urol. 2018. PMID: 29721611 Free PMC article.

179

The diagnostic accuracy of methylation markers in urine for the detection of bladder cancer: a systematic review.

Bosschieter J, Lutz C, Segerink LI, Vis AN, Zwarthoff EC, A van Moorselaar RJ, van Rhijn BW, Heymans MW, Jansma EP, Steenbergen RD, Nieuwenhuijzen JA. Bosschieter J, et al. Among authors: van rhijn bw. Epigenomics. 2018 May;10(5):673-687. doi: 10.2217/epi-2017-0156. Epub 2018 Apr 25. Epigenomics. 2018. PMID: 29692199

180

Pathogenic and targetable genetic alterations in 70 urachal adenocarcinomas.

Reis H, van der Vos KE, Niedworok C, Herold T, Módos O, Szendrői A, Hager T, Ingenwerth M, Vis DJ, Behrendt MA, de Jong J, van der Heijden MS, Peyronnet B, Mathieu R, Wiesweg M, Ablat J, Okon K, Tolkach Y, Keresztes D, Nagy N, Bremmer F, Gaisa NT, Chlosta P, Kriegsmann J, Kovalszky I, Timar J, Kristiansen G, Radzun HJ, Knüchel R, Schuler M, Black PC, Rübben H, Hadaschik BA, Schmid KW, van Rhijn BWG, Nyirády P, Szarvas T. Reis H, et al. Among authors: van rhijn bwg. Int J Cancer. 2018 Oct 1;143(7):1764-1773. doi: 10.1002/ijc.31547. Epub 2018 May 10. Int J Cancer. 2018. PMID: 29672836

181

Mechanistic target of rapamycin (MTOR) protein expression in the tumor and its microenvironment correlates with more aggressive pathology at cystectomy.

Winters BR, Vakar-Lopez F, Brown L, Montgomery B, Seiler R, Black PC, Boormans JL, Dall Era M, Davincioni E, Douglas J, Gibb EA, van Rhijn BWG, van der Heijden MS, Hsieh AC, Wright JL, Lam HM. Winters BR, et al. Among authors: van rhijn bwg. Urol Oncol. 2018 Jul;36(7):342.e7-342.e14. doi: 10.1016/j.urolonc.2018.03.016. Epub 2018 Apr 12. Urol Oncol. 2018. PMID: 29657089 Free article.

182

The World Health Organization 1973 classification system for grade is an important prognosticator in T1 non-muscle-invasive bladder cancer.

van de Putte EEF, Bosschieter J, van der Kwast TH, Bertz S, Denzinger S, Manach Q, Compérat EM, Boormans JL, Jewett MAS, Stoehr R, van Leenders GJLH, Nieuwenhuijzen JA, Zlotta AR, Hendricksen K, Rouprêt M, Otto W, Burger M, Hartmann A, van Rhijn BWG. van de Putte EEF, et al. Among authors: van rhijn bwg. BJU Int. 2018 Dec;122(6):978-985. doi: 10.1111/bju.14238. Epub 2018 Apr 27. BJU Int. 2018. PMID: 29637669

183

Intravesical recurrence after bladder sparing treatment of small cell carcinoma of the bladder: Characteristics, treatment, and outcome.

van de Kamp M, Meijer R, Pos F, Kerst M, van Werkhoven E, van Rhijn B, Horenblas S, Bex A. van de Kamp M, et al. Among authors: van rhijn b. Urol Oncol. 2018 Jun;36(6):307.e1-307.e8. doi: 10.1016/j.urolonc.2018.02.015. Epub 2018 Mar 23. Urol Oncol. 2018. PMID: 29580697 Clinical Trial.

184

Sarcopenia predicts 90-day mortality and postoperative complications after radical cystectomy for bladder cancer.

Mayr R, Fritsche HM, Zeman F, Reiffen M, Siebertz L, Niessen C, Pycha A, van Rhijn BWG, Burger M, Gierth M. Mayr R, et al. Among authors: van rhijn bwg. World J Urol. 2018 Aug;36(8):1201-1207. doi: 10.1007/s00345-018-2259-x. Epub 2018 Mar 8. World J Urol. 2018. PMID: 29520591

185

Recommendations for follow-up of muscle-invasive bladder cancer patients: A consensus by the international bladder cancer network.

Zuiverloon TCM, van Kessel KEM, Bivalacqua TJ, Boormans JL, Ecke TH, Grivas PD, Kiltie AE, Liedberg F, Necchi A, van Rhijn BW, Roghmann F, Sanchez-Carbayo M, Schmitz-Dräger BJ, Wezel F, Kamat AM. Zuiverloon TCM, et al. Among authors: van rhijn bw. Urol Oncol. 2018 Sep;36(9):423-431. doi: 10.1016/j.urolonc.2018.01.014. Epub 2018 Mar 2. Urol Oncol. 2018. PMID: 29496372 Review.

186

Sarcopenia as a comorbidity-independent predictor of survival following radical cystectomy for bladder cancer.

Mayr R, Gierth M, Zeman F, Reiffen M, Seeger P, Wezel F, Pycha A, Comploj E, Bonatti M, Ritter M, van Rhijn BWG, Burger M, Bolenz C, Fritsche HM, Martini T. Mayr R, et al. Among authors: van rhijn bwg. J Cachexia Sarcopenia Muscle. 2018 Jun;9(3):505-513. doi: 10.1002/jcsm.12279. Epub 2018 Feb 25. J Cachexia Sarcopenia Muscle. 2018. PMID: 29479839 Free PMC article.

187

Infiltrative lamina propria invasion pattern as an independent predictor for cancer-specific and overall survival of instillation treatment-naïve stage T1 high-grade urothelial bladder cancer.

Otto W, van Rhijn BW, Breyer J, Bertz S, Eckstein M, Mayr R, Lausenmeyer EM, Denzinger S, Burger M, Hartmann A. Otto W, et al. Among authors: van rhijn bw. Int J Urol. 2018 May;25(5):442-449. doi: 10.1111/iju.13532. Epub 2018 Feb 22. Int J Urol. 2018. PMID: 29473226

188

Grading of Urothelial Carcinoma and The New "World Health Organisation Classification of Tumours of the Urinary System and Male Genital Organs 2016".

Compérat EM, Burger M, Gontero P, Mostafid AH, Palou J, Rouprêt M, van Rhijn BWG, Shariat SF, Sylvester RJ, Zigeuner R, Babjuk M. Compérat EM, et al. Among authors: van rhijn bwg. Eur Urol Focus. 2019 May;5(3):457-466. doi: 10.1016/j.euf.2018.01.003. Epub 2018 Jan 20. Eur Urol Focus. 2019. PMID: 29366854 Review.

189

Neoadjuvant Dose Dense MVAC versus Gemcitabine and Cisplatin in Patients with cT3-4aN0M0 Bladder Cancer Treated with Radical Cystectomy.

Zargar H, Shah JB, van Rhijn BW, Daneshmand S, Bivalacqua TJ, Spiess PE, Black PC, Kassouf W; Collaborators. Zargar H, et al. Among authors: van rhijn bw. J Urol. 2018 Jun;199(6):1452-1458. doi: 10.1016/j.juro.2017.12.062. Epub 2018 Jan 9. J Urol. 2018. PMID: 29329894

190

Lymphatic Drainage from Renal Tumors In Vivo: A Prospective Sentinel Node Study Using SPECT/CT Imaging.

Kuusk T, De Bruijn R, Brouwer OR, De Jong J, Donswijk M, Grivas N, Hendricksen K, Horenblas S, Prevoo W, Valdés Olmos RA, Van Der Poel HG, Van Rhijn BWG, Wit EM, Bex A. Kuusk T, et al. Among authors: van rhijn bwg. J Urol. 2018 Jun;199(6):1426-1432. doi: 10.1016/j.juro.2017.11.112. Epub 2017 Dec 6. J Urol. 2018. PMID: 29223390

191

Short-term outcome after cystectomy: comparison of early oral feeding in an enhanced recovery protocol and feeding using Bengmark nasojejunal tube.

Voskuilen CS, van de Putte EEF, der Hulst JB, van Werkhoven E, de Blok WM, van Rhijn BWG, Horenblas S, Meijer RP. Voskuilen CS, et al. Among authors: van rhijn bwg. World J Urol. 2018 Feb;36(2):221-229. doi: 10.1007/s00345-017-2133-2. Epub 2017 Nov 22. World J Urol. 2018. PMID: 29167985 Free PMC article.

192

Potential Benefit of Lymph Node Dissection During Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the European Association of Urology Guidelines Panel on Non-muscle-invasive Bladder Cancer.

Dominguez-Escrig JL, Peyronnet B, Seisen T, Bruins HM, Yuan CY, Babjuk M, Böhle A, Burger M, Compérat EM, Gontero P, Lam T, MacLennan S, Mostafid H, Palou J, van Rhijn BWG, Sylvester RJ, Zigeuner R, Shariat SF, Rouprêt M. Dominguez-Escrig JL, et al. Among authors: van rhijn bwg. Eur Urol Focus. 2019 Mar;5(2):224-241. doi: 10.1016/j.euf.2017.09.015. Epub 2017 Nov 20. Eur Urol Focus. 2019. PMID: 29158169

193

Oncological Outcomes of Laparoscopic Nephroureterectomy Versus Open Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: An European Association of Urology Guidelines Systematic Review.

Peyronnet B, Seisen T, Dominguez-Escrig JL, Bruins HM, Yuan CY, Lam T, Maclennan S, N'dow J, Babjuk M, Comperat E, Zigeuner R, Sylvester RJ, Burger M, Mostafid H, van Rhijn BWG, Gontero P, Palou J, Shariat SF, Roupret M. Peyronnet B, et al. Among authors: van rhijn bwg. Eur Urol Focus. 2019 Mar;5(2):205-223. doi: 10.1016/j.euf.2017.10.003. Epub 2017 Nov 15. Eur Urol Focus. 2019. PMID: 29154042

194

Neoadjuvant treatment for muscle-invasive bladder cancer: The past, the present, and the future.

Hermans TJN, Voskuilen CS, van der Heijden MS, Schmitz-Dräger BJ, Kassouf W, Seiler R, Kamat AM, Grivas P, Kiltie AE, Black PC, van Rhijn BWG. Hermans TJN, et al. Among authors: van rhijn bwg. Urol Oncol. 2018 Sep;36(9):413-422. doi: 10.1016/j.urolonc.2017.10.014. Epub 2017 Nov 8. Urol Oncol. 2018. PMID: 29128420 Review.

195

Discrepancy Between European Association of Urology Guidelines and Daily Practice in the Management of Non-muscle-invasive Bladder Cancer: Results of a European Survey.

Hendricksen K, Aziz A, Bes P, Chun FK, Dobruch J, Kluth LA, Gontero P, Necchi A, Noon AP, van Rhijn BWG, Rink M, Roghmann F, Rouprêt M, Seiler R, Shariat SF, Qvick B, Babjuk M, Xylinas E; Young Academic Urologists Urothelial Carcinoma Group of the European Association of Urology. Hendricksen K, et al. Among authors: van rhijn bwg. Eur Urol Focus. 2019 Jul;5(4):681-688. doi: 10.1016/j.euf.2017.09.002. Epub 2017 Oct 23. Eur Urol Focus. 2019. PMID: 29074050

196

European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update.

Rouprêt M, Babjuk M, Compérat E, Zigeuner R, Sylvester RJ, Burger M, Cowan NC, Gontero P, Van Rhijn BWG, Mostafid AH, Palou J, Shariat SF. Rouprêt M, et al. Among authors: van rhijn bwg. Eur Urol. 2018 Jan;73(1):111-122. doi: 10.1016/j.eururo.2017.07.036. Epub 2017 Sep 1. Eur Urol. 2018. PMID: 28867446 Review.

197

Increased Proliferation as Independent Predictor of Disease Recurrence in Initial Stage pTa Urothelial Bladder Cancer.

Breyer J, Shalekenov S, Aziz A, van Rhijn BWG, Bründl J, Lausenmeyer E, Schäfer J, Denzinger S, Giedl C, Burger M, Hartmann A, Evert M, Otto W. Breyer J, et al. Among authors: van rhijn bwg. Bladder Cancer. 2017 Jul 27;3(3):173-180. doi: 10.3233/BLC-170103. Bladder Cancer. 2017. PMID: 28824945 Free PMC article.

198

Endo-Urological Techniques for Benign Uretero-Ileal Strictures Have Poor Efficacy and Affect Renal Function.

Fransen van de Putte EE, de Wall LL, van Werkhoven E, Heldeweg EA, Bex A, van der Poel HG, van Rhijn BWG, Horenblas S, Hendricksen K. Fransen van de Putte EE, et al. Among authors: van rhijn bwg. Urol Int. 2018;100(1):18-24. doi: 10.1159/000475508. Epub 2017 Aug 18. Urol Int. 2018. PMID: 28817820

199

Lack of Effectiveness of Postchemotherapy Lymphadenectomy in Bladder Cancer Patients with Clinical Evidence of Metastatic Pelvic or Retroperitoneal Lymph Nodes Only: A Propensity Score-based Analysis.

Necchi A, Mariani L, Lo Vullo S, Yu EY, Woods ME, Wong YN, Harshman LC, Alva A, Sternberg CN, Bamias A, Grivas P, Koshkin VS, Roghmann F, Dobruch J, Eigl BJ, Nappi L, Milowsky MI, Niegisch G, Pal SK, De Giorgi U, Recine F, Vaishampayan U, Berthold DD, Bowles DW, Baniel J, Theodore C, Ladoire S, Srinivas S, Agarwal N, Crabb S, Sridhar S, Golshayan AR, Ohlmann C, Xylinas E, Powles T, Rosenberg JE, Bellmunt J, van Rhijn B, Galsky MD, Hendricksen K; Young Academic Urologists-Urothelial Carcinoma Group-European Association of Urology and the Retrospective International Study of Invasive/Advanced Cancer of the Urothelium group. Necchi A, et al. Among authors: van rhijn b. Eur Urol Focus. 2019 Mar;5(2):242-249. doi: 10.1016/j.euf.2017.05.006. Epub 2017 Jun 3. Eur Urol Focus. 2019. PMID: 28753897 Free PMC article.

200

Association Of Plasma And Urinary Mutant DNA With Clinical Outcomes In Muscle Invasive Bladder Cancer.

Patel KM, van der Vos KE, Smith CG, Mouliere F, Tsui D, Morris J, Chandrananda D, Marass F, van den Broek D, Neal DE, Gnanapragasam VJ, Forshew T, van Rhijn BW, Massie CE, Rosenfeld N, van der Heijden MS. Patel KM, et al. Among authors: van rhijn bw. Sci Rep. 2017 Jul 17;7(1):5554. doi: 10.1038/s41598-017-05623-3. Sci Rep. 2017. PMID: 28717136 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

316 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

316 results

Results by year